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The Role of Bcl-2 Modifying Factor (Bmf) in Airway Epithelial
Cell Death
By
Amelia H.T. Unione
B.S. Health Science Studies, Boise State University, 2001

ABSTRACT
One of the components that obstruct the airway in asthma is the sudden and
increased secretion of mucus from metaplastic mucous cells in small airways. Because
previous studies have shown that the resolution of mucous cell metaplasia (MCM) during
prolonged exposure of mice to allergen is mediated by IFNγ and the Bcl-2 family of
proteins, we investigated the regulation and the role of a pro-apoptotic BH3 domain-only
protein, Bmf, in airway epithelial cells (AECs) treated with IFNγ. We hypothesize that
Bmf is crucial for IFNγ-induced cell death. Our findings show that IFNγ suppressed Bmf
expression in a p53-dependent manner. IFNγ treatment caused nuclear accumulation,
increased association of p53 with HDAC1, the reduction of acetylated p53, and the
interaction of p53 with the Bmf promoter. This reduction was primarily of the higher
molecular weight Bmf that was found to increase cell colony formation in vitro. Bmf
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was important for the resolution of MCM during prolonged exposure to allergen because
the mucous cell numbers did not decline in bmf-/- mice compared to wild-type controls
during prolonged exposure to allergen. In addition, bmf-/- mouse airway epithelial cells
(MAECs) were resistant to IFNγ-induced cell death. Previous studies in cancer cell lines
have shown that Bmf mediates cell death in response to histone deacetylase inhibitors
(HDACis). We found that HDACis increased expression of Bmf in AECs through the
displacement of HDAC1 and the acetylation of histones 3 and 4 associated with the Bmf
promoter. Bmf-deficient AECs were resistant to HDACi-induced cell death, while
expressing Bmf in the bmf-/- MAECs restored this cell death process demonstrating that
Bmf is a critical mediator of this cell death process. In conclusion, these findings show
that Bmf mediates IFNγ- and HDACi-induced cell death in AECs and implies that
HDACis may be useful for treatment of cancers and for reducing AEC hyperplasia and
MCM, thereby reducing mucous hypersecretions and airway obstruction in chronic
diseases.
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1.1 Mechanisms involved in apoptotic cell death
The Nomenclature Committee on Cell Death has described four modalities of cell
death: apoptosis, necrosis, autophagy, and cornification 1. They are all forms of
programmed cell death because they are regulated at the genetic and cellular level.
Another important modality is senescence, a state in which growth and proliferation are
arrested. In vivo studies report that senescence may be important for tumor suppression
2

. Apoptosis is a process by which tissues remove unwanted or damaged cells. This type

of cell death is an important part of healthy tissue homeostasis and mammalian
development, but when dysregulated can result in disease, such as cancer and
autoimmunity 3. Two well-characterized pathways mediate apoptosis: the extrinsic and
the intrinsic. In either case, caspase proteases are ultimately responsible for killing the
cell. Apoptosis manifests as cellular blebbing and shrinkage, DNA fragmentation, or
changes in the plasma membrane 4.
Extrinsic cell death otherwise known as the death receptor pathway is initiated
when specific ligands bind to cell death receptors located on the cell surface. These
receptors belong to the tumor necrosis factor (TNF) family and include Fas receptor and
TNF receptor 1 (TNFR-1). This interaction activates initiator caspase-8 and -10, which
in turn activate the appropriate effector caspases 5.
The intrinsic cell death pathway or mitochondrial death pathway is caused by
various cellular stressors, such as DNA damage, cytoskeletal damage, loss of adhesion,
growth factor withdrawal, macromolecular synthesis inhibition, and others 6. Complex
interactions between the anti-apoptotic and the pro-apoptotic members of the Bcl-2
family of proteins regulate the integrity of the outer mitochondrial membrane (OMM).
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The permeabilization of the mitochondrial membrane is the initial step in this process,
allowing for the release of several pro-apoptotic factors such as cytochrome c, second
mitochondria-derived activator of caspases (Smac/Diablo), apoptosis-inducing factor
(AIF), endonuclease G, and HtrA2/omi 7. Cytochrome c oligomerizes with adaptor
protein (Apaf-1), and forms a scaffold called the apoptosome complex. The apoptosome
binds and activates pro-caspase-9, activating executioner caspases-3 and -7, and killing
the cell 4, 7, 8.
The endoplasmic reticulum (ER) can induce apoptosis as a way to protect from
stresses, such as unfolded protein response (UPR) characterized by the accumulation and
aggregation of proteins in the ER lumen or inhibition of protein transport from the ER to
the Golgi. An early part of the ER-induced apoptotic response is the release of calcium
into the cytosol. Although initiated by the ER, this type of apoptosis is dependent on the
mitochondria and members of the Bcl-2 family of proteins. Health conditions such as
ischemia, viral infections, and neurodegenerative diseases are associated with a reduction
in cell number caused by ER stress-induced apoptosis 9.

1.2 Regulation of apoptosis by the Bcl-2 family
The Bcl-2 family of proteins consists of both anti-apoptotic and pro-apoptotic
members. These proteins share conserved α-helical regions called Bcl-2 homology (BH)
regions 10. Structurally, these proteins are categorized as folded globular proteins and
intrinsically unstructured proteins 4.
The first subgroup consists of five anti-apoptotic proteins with all four BH
regions, which are B-cell lymphoma 2 (Bcl-2), Bcl-2-related gene long isoform (Bcl-xL),
B-cell-2-like 2 (Bcl-w), myeloid cell leukemia sequence 1 (Mcl-1), and Bcl-2-related
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gene A1 (A1). All of these anti-apoptotic Bcl-2 proteins are anchored in the OMM or in
the ER membrane, or are found in the cytoplasm. These proteins protect from cell death
by inhibiting the function of pro-apoptotic proteins 1, 4.
Bcl-2 antagonist killer 1 (Bak) and Bcl-2-associated x protein (Bax) are proapoptotic and referred to as effector proteins. They possess homology domains BH1BH3, although a BH4 motif has recently been reported 11. Upon activation of Bax and
Bak, they homo-oligomerize and insert into the pores of the OMM causing mitochondrial
membrane permeabilization, the essential initiation step for apoptosis. Bax and Bak are
found on both the mitochondrial and ER membranes 1, 4 and are central in the cell death
pathway because deletion of both genes renders cells resistant to death induced by ER
stressors and DNA damage 12.
Members of the third subgroup of the Bcl-2 family are also pro-apoptotic but
contain only one homology region and are therefore called the BH3 domain-only
proteins. Eleven BH3 domain-only proteins have been identified7, some of which include
BH3-interacting-domain death agonist (Bid), Bcl-2-associated death promoter (Bad),
Noxa or PMAIp1, Bcl-2 interacting killer (Bik), Bcl-2-modifying factor (Bmf), Harakari
(Hrk), p53-upregulated modulator of apoptosis (Puma), and Bcl-2 interacting mediator of
cell death (Bim) 1, 4. The BH3-only proteins are regarded as sentinels, responding to
stress signals and developmental cues 7. A conserved leucine residue within the BH3
domain, when mutated, renders these proteins unable to interact with the anti-apoptotic
Bcl-2 family members 13, 14.
Two models have been proposed to categorize the function of the Bcl-2 family
members: the indirect activation model and the direct activation model 7. Indirect
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activation implies that an anti-apoptotic protein sequesters Bax and Bak to block their
pro-apoptotic effects. An apoptotic stimulus activates a BH3 domain-only protein, which
binds to the hydrophobic cleft of the anti-apoptotic protein, releasing Bax and Bak to kill
the cell 1. Direct activation implies that Bax and Bak are activated directly by binding to
BH3 domain-only proteins. Within this model, the BH3-only proteins are subdivided
into two groups: direct activators and sensitizers/de-repressors. Bim and Bid are
considered direct activators, while Bad, Bik, Bmf, Hrk, Noxa, and Puma are
sensitizers/de-repressors 1, 4. These sensitizers bind and inactivate an anti-apoptotic
protein and thereby unleash the pro-apoptotic potential of a direct activator. Similarly,
according to the derepression theory, the activator remains sequestered or bound by the
anti-apoptotic protein and is released only after an apoptotic stimuli causes the sensitizer
protein to compete for the binding site that the activator occupies, freeing the activator to
bind and activate Bak and Bax, leading to cell death 1, 4.
In addition to the apoptotic signal causing specific BH3 only-domain proteins to
be activated, cell type also dictates the function of the BH3 domain-only protein. For
instance, the BH3 domain-only Bik is not important for cell death in hematopoietic cells
15

; however, it is critical for IFNγ-induced cell death in AECs 16.

1.3 The BH3 domain-only protein Bmf
Bmf is an important mediator for a diverse group of cell death-causing stimuli
including detachment- (anoikis), arsenic trioxide-, TNFα-, TGFβ-, and HDACi-induced
cell death 17-21. Bmf sensitizes mammary epithelial cells to anoikis, but cannot initiate
cell death on its own 20. The gene for Bmf is located on chromosome 15q14, which is
also the site of a tumor suppressor gene thought to be involved in metastasis 22. Because
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anoikis may inhibit metastatic tumor growth23, Bmf is believed to be involved in
metastatic cancers. Studies demonstrating that Bmf may function as a mammary
epithelial tumor suppressor include findings that show the down-regulation of Bmf
suppresses anoikis and luminal cell death, promoting anchorage independent growth.
Bmf is also said to be a target for a proliferative oncogene, HPV16E7 10.
Bmf possesses a conserved sequence motif that binds to the dynein light chain
(DLC), a part of the myosin V motor complex in the cytoskeleton. In response to
particular stresses, Bmf detaches and translocates to the mitochondria (Figure 1-1) where
it interacts with Bcl-2 10. Cytosolic translocation of Bmf is also observed by MEK
inhibition that induces cell death in melanoma cells. However, in MEK-inhibitionresistant melanoma cells Bmf remains tethered to the cytoskeleton, and mutation of the
region that tethers Bmf to the cytoskeleton increases the killing potential of Bmf 24. In
vitro, biochemical assays in HEK293 cells demonstrate that apoptotic activity of Bmf is
mediated by JNK phosphorylation at Ser 74 for Bmf 25, 26. Although, in vivo experiments
in mice with knock-in mutations disrupting this phosphorylation site demonstrate that
phosphorylation is not essential for normal Bmf activity 26.
Within the hematopoietic compartment Bmf is important for B cell homeostasis.
Bmf-deficient mice exhibit B-cell hyperplasia as well as an increased sensitivity to γradiation-induced B-cell lymphoma 27. In addition, Bmf prohibits C-Myc- driven B cell
lymphomagenesis, and the loss of Bmf in transgenic Eµ–myc/bmf -/- mice results in tumor
formation because of the accumulation of preneoplastic pre-B and immature IgM+ B cells
in the bone marrow of these mice 21.
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We and others have observed that Bmf is regulated at the transcriptional level in
various cell types19, 20, 27, but expression is also regulated post-transcriptionally through
microRNAs and post-translational modifications 10, 28, 29. In vitro experiments in Bchronic lymphocytic leukemia cells demonstrated that the Bmf gene is alternatively
spliced and produces three isoforms: Bmf, Bmf II, and Bmf III. Bmf is the only isoform
possessing a BH3 domain, while all three have a DLC- binding domain 18.
In cancer cell lines, transcription of Bmf is regulated by the chromatin remodeling
enzymes histone deacetylases (HDACs) and histone acetyltransferases (HATs) 19.
HDACs fall into three classes, I, II, and III, and are important for cellular regulation
through the transcriptional control of genes 30. HDACs catalyze the removal of acetyl
groups from the amino-terminal residues of histones causing chromatin condensation,
which shuts off transcription; HATs increase transcription through the transfer of acetyl
groups to histones and relaxing the chromatin. Therefore, inhibiting HDAC activity
increases transcription. Bmf is critical for cell death caused by the HDAC inhibitors
(HDACis) FK228 and CBHA in cancer cell lines 19 and by SAHA
(suberoylanilidehydroximic acid) in thymocytes and pre-B cells. However, Bmf does not
mediate TSA or CBHA-induced cell death in T or pre-B cells 27. The present studies
elucidate the role of HDACis in regulating Bmf expression and mediating HDACiinduced cell death in AECs.

1.4 Regulation of airway epithelial cell number in asthma
The prevalence of allergen-induced asthma is dramatically increasing in children
and adults worldwide 31. Cytokines that are important in the allergen-specific
inflammatory response in asthma are produced by Th2 helper cells and include IL-4, IL-
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5, IL-9, and IL-13. IL-2 and IFNγ are produced by Th1 helper cells 32. Il-13 induces the
differentiation of AECs into mucous-secreting cells, termed MCM, thereby increasing the
mucus content in the airway epithelium and causing obstruction of the airways 33, 34. In
addition to MCM, patients with asthma have a fragile airway epithelium, in which the
epithelial cells are more susceptible to shedding 35. In AECs obtained by bronchial
brushing, we found that Bmf mRNA is significantly induced in patients with asthma
compared to non-diseased controls (unpublished data). In the present studies, we used an
animal model of asthma to study Th2 cytokine-induced changes in epithelial cell
numbers. Mice are sensitized with alum/OVA and exposed to ovalbumin aerosols to
induce an allergic Th2 response 31. This exposure causes airway epithelial cell
hyperplasia and MCM in C57BL/6 mice 36, 37. When mice are repeatedly exposed to
allergen for prolonged periods, MCM is reduced, and this reduction involves cell death of
epithelial cells. The resolution of these hyperplastic cells appears to involve detachment
of the airway cells from the basement membrane.

1.5 The role of IFNγ in the resolution of MCM
Studies show that instillation of IFNγ causes an accelerated resolution of allergeninduced MCM. When IFNγ-/- and Stat1-/- mice are sensitized and exposed to allergen for
prolonged periods, MCM is not resolved. This demonstrates that the cytokine IFNγ
through Stat 1 activation is a key mediator in the reduction of allergen-induced MCM by
inducing apoptosis 16, 37.
IFNγ is the only cytokine belonging to the Type II interferon family and is
secreted by natural killer cells and T lymphocytes in response to specific antigens and
mitogens 38. IFNγ binds to IFNγ-R1, inducing the Jak-Stat-signaling pathway 39. Cell
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death is induced by IFNγ in many different cell lines, including colon adenocarcinoma
cells, A549 lung epithelial cells, primary human keratinocytes, HeLa cells, breast tumor
cells, fibroblasts, and AECs 37. The IFNγ-induced apoptotic pathway varies among cell
types; the extrinsic pathway is the pathway for apoptosis in erythrocytes, keratinocytes,
and T-lymphocytes 39, 40. However, in AECs IFNγ induces cell death 37 by involving
certain members of the Bcl2 family, but mitochondrial cytochrome c release was not
detected 41. This type of cell death is accompanied by changes at the ER; IFNγ causes
translocation of the effector protein Bax to the ER causing ER dilation and reduction of
calcium stores 41. Recent work has shown that pro-apoptotic BH3 domain-only Bik is a
critical mediator of IFNγ-induced AEC death in a STAT1 dependent manner. In vivo
studies demonstrating that allergen-induced AEC hyperplasia is not resolved in Bikdeficient mice during prolonged exposure to allergen 16 confirms the importance of Bik in
this resolution process. The anti-apoptotic Bcl-2 is also important for resolution of
hyperplastic as well as metaplastic mucous cells 36, 42, 43. The present studies investigated
the role of Bmf in regulating AEC numbers.

1.6 p53 and apoptosis
Mutations in the tumor suppressor protein 53 (p53) have been implicated in half
of all human cancers suggesting that this protein plays a major role in cellular
homeostasis 44. In the nucleus, p53 is responsible for regulating hundreds of genes
involved in cell cycle progression, apoptosis, preventing apoptosis, senescence, DNA
repair, metabolism, and autophagy44, 45, and is therefore a critical component of the
cellular response to stress, including DNA damage and the UPR. In the cytosol, p53
triggers mitochondrial membrane permeabilization by binding and activating Bax or
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inhibiting Bcl-2 and Bcl-xL6. p53 is regulated through MDM2-mediated ubiquitination
followed by proteosomal degradation. Post-translational modifications including
phosphorylation, methylation, and acetylation also regulate the function of p53 44.
Biochemical and cell culture studies have shown that 36 different amino acids can
undergo modifications in response to cellular stresses 44. Because p53 is central in cell
death processes 46, we examined its role in regulating Bmf during the cell death process
of AECs.

1.7 Hypothesis
We hypothesize that p53 suppresses IFNγ-induced Bmf expression, and that Bmf is
critical for both IFNγ- and HDACi-induced cell death in airway epithelial cells.
Our specific aims are:
 To investigate the regulation of Bmf by IFNγ and the suppressive activity of
p53.
 To investigate the regulation and role of Bmf in AECs in response to inhibition
of HDAC.
 To investigate whether Bmf is necessary for the IFNγ-induced resolution of
AECs during prolonged exposure of mice to allergen.
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1.8 Model

Figure 1-1. Model demonstrating how Bmf responds to apoptotic stimuli Puthalakath et
al. 1) Under normal conditions Bmf resides in the actin cytoskeleton attached to the
dynein light chain. 2) In response to apoptotic stimuli such as UV exposure, Bmf
translocates from the cytoskeleton to the mitochondria and causes cell death.
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2.1 Abstract
IFNγ induces cell death not only in various cancer cells but also in primary keratinocytes,
fibroblasts, and airway epithelial cells (AECs). Therefore, it has been used for the treatment
of various cancers and our studies show that IFNγ reduces airway epithelial cell hyperplasia
during prolonged exposure of mice to allergen. However, the effect of IFNγ on p53, a major
tumor suppressor gene, has not been studied. When screening for Bcl-2 family of proteins
involved in the IFNγ-induced cell death pathway we found that IFNγ, in a p53-dependent
manner, downregulated expression of the BH3 domain-only protein, Bmf, in human (HAECs)
and mouse (MAECs) primary airway epithelial cells. p53 also suppressed Bmf expression in
response to other cell death stimulating agents including UV light and histone deacetylase
inhibitors. IFNγ did not affect Bmf mRNA half-life but increased nuclear p53 levels and
increased the interaction of p53 with the Bmf promoter. IFNγ suppressed Bmf expression
also in MAECs derived from mice that lack the proline-rich domain of p53, and increasing
p53 levels with nutlin 3 failed to modify the suppressive effect of IFNγ or UV light.
Immunoprecipitation with p53 antibodies showed that an increased interaction of HDAC1
with p53 in IFNγ-treated cells was accompanied by a reduction in the acetylated form of p53.
Collectively, these studies show that IFNγ treatment increases nuclear p53 accumulation,
interaction of p53 with HDAC1, and p53 deacetylation to suppress Bmf expression.
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2.2 Introduction
IFNγ induces apoptosis in a variety of cell types, including carcinoma1,2 and
primary keratinocytes 3. IFNγ also induces cell death in AECs 4 to remove hyperplastic
epithelial cells following inflammation-induced epithelial cell hyperplasia by activating
STAT15. This cell death pathway requires the BH3-only protein Bik6 and the
translocation of Bax to the endoplasmic reticulum (ER)7, 8. However, the effect of IFNγ
on p53 has not been reported.
The Bcl-2 family of proteins is characterized by the Bcl-2 homology (BH)
domains. The pro-survival proteins Bcl-2, BclxL, and Mcl-1 have four BH domains
(BH1-4). The first group of pro-apoptotic proteins, Bax, Bak, and Bok are characterized
by three (BH1-3), while the second group contains only the BH3 domain and, therefore,
is also designated the BH3-only group of proteins 9. One of the BH3-only proteins, Bmf,
was first reported to cause cell death upon loss of cell attachment by being released from
the DLC and inhibiting the function of the pro-survival Bcl-210. However, this was not
confirmed in Bmf-deficient mice 11 that display defects in uterovaginal development 12.
The expression of Bmf induced during formation of the lumen in mammary epithelial
acinar structures and the involution of the mouse mammary gland 13. Bmf was identified
as a requirement for necroptosis induced by either zVAD.fmk or TNFα in L929 cells 14
and for HDAC inhibitor-induced apoptosis 13. Because we have observed that resolution
of airway epithelial cells may involve anoikis, and IFNγ causes resolution of epithelial
cell hyperplasia 7, 4 we investigated the effect of IFNγ on Bmf expression in airway
epithelial cells.
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While the function of Bmf has been studied more extensively, understanding is
lacking on how its expression is regulated. Bmf expression is increased 500-fold during
maturation of oligodendroglial progenitor cells to mature oligodendrocytes 15. Bmf
expression is induced by arsenic trioxide in multiple myeloma cells and mediates cell
death 16. The mechanism involved in Bmf expression in oligodendrocyte maturation, by
arsenic trioxide, or mammary cells was not reported. However, histone deacetylase
inhibitors (HDACis) preferentially induce Bmf expression in a broad range of cancer
cells by hyperacetylating histones H3 and H4 at the Bmf promoter region 17. In addition,
loss of Bmf protein renders resistance to lymphocytes against glucocorticoid- or HDAC
inhibitor-induced cell death 11. While the designation HDACs is based on these proteins
being initially known to primarily target histones, it is now clear that many other nonhistone proteins are substrates for the various HDACs. p53 was the first non-histone
protein known to be regulated by acetylation and deacetylation 18, 19. In the present study,
we found that in airway epithelial cells IFNγ causes deacetylation and nuclear
accumulation of p53 to promote interaction with the Bmf promoter and suppress
expression.
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2.3 Experimental Procedures
Animals
Pathogen-free STAT1-/-, p53+/- mice were purchased from the Jackson Laboratory
(Bar Harbor, ME), bik-/- mice were made available by Dr. Andreas Strasser (Walter and
Eliza Hall Institute) and mice with modified proline-rich domain p53ΔP, and p53AXXA
were from Dr. Geoffrey M. Wahl (The Salk Institute for Biological Studies, La Jolla,
CA). These mice along with the wild-type littermates were bred at the Lovelace
Respiratory Research Institute (LRRI) under specific pathogen-free conditions and
genotyped as described previously 11. All animal experiments were approved by the
Institutional Animal Care and Use Committee at Lovelace Respiratory Research Institute,
a facility approved by the Association for the Assessment and Accreditation for
Laboratory Animal Care International.
Cell Culture
The preparation of MAECs was carried out as described 20. The immortalized
human airway epithelial cells, AALEB cells 8, and HAECs (Clontech, Walkersville, MD)
were maintained in bronchial epithelial growth medium (BEGM, Lonza, Walkersville,
MD)
RNA Extraction and quantitative RT-PCR
Extraction of RNA from cell pellets was carried out using the RNeasy kit
(Qiagen, Valencia, CA) and concentrations were determined using the Thermo Scientific
Nanodrop 1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA). The
primer/probe sets for Bmf, CDKN1B, and 18s were obtained from Applied Biosystems
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(Foster City, CA). Target mRNAs were amplified by quantitative real-time PCR in 20 µl
reactions on the ABIPRISM 7900HT Real-Time PCR System using the One-Step RTPCR Master Mix (Applied Biosystems). Relative quantities from duplicate
amplifications were calculated by normalizing averaged CT values to CDKN1B and/or
18s to obtain ΔCt, and the relative standard curve method was used for determining the
fold change as described 21.
Western Blot Analysis
Preparation of protein lysates and cytosolic and nuclear fractions were prepared 6
and analyzed by Western blotting as described 8. We used the rat anti-Bmf monoclonal
antibody, a gift from Dr. Andreas Strasser (the Walter and Eliza Hall Institute of Medical
Research, Melbourne, Australia) at 2 µg/ml, the rabbit anti-p53 polyclonal antibody (FL393, Santa Cruz Biotechnology Inc., CA) or acetyl-p53 (Lys 382) (Cell Signaling Inc.,
Boston, MA) at a 1:1000 dilution. Mouse actin polycolonal antibody was used at 1:5000
dilution (Santa Cruz Biotechnology, Inc.) and rabbit anti-lamin polyclonal antibody was
used at 1:1000 dilution (#2032 Cell Signaling, Inc. Boston, MA), and rabbit anti-HDAC1
polyclonal antibody was used at 1:1000 dilution (Millipore, Billerica, MA). Goat anti-rat
or goat anti-rabbit secondary antibodies were used for visualizing proteins with
chemiluminescence (Perkin Elmer, Waltham, Massachusetts) using the FujiFilm Image
Reader LAS-4000 (Valhalla, NY).
Immunofluorescent Imaging and Analysis
For immunofluorescent staining AALEB cells were grown on Lab-Tek-II 8chamber slides (Nalge Nunc International, Rochester, NY) and treated with 50 ng/ml of
IFNγ or left untreated. Cells were fixed using 3% paraformaldehyde with 3% sucrose in
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PBS and permeabilized using 0.2% Triton X-100 with 0.2% Saponin in a blocking
solution containing 3% IgG-free BSA, 1% gelatin, and 2% normal donkey serum. The
cells were then probed with anti-p53 (#sc126, clone DO1, Santa Cruz Biotech, CA), antiacetyl-p53 (Lys382) (#2525, Cell Signaling, Inc. Boston, MA) or isotype controls at
1:100 dilution. The immunolabeled cells were detected using F(ab)2-fragments of
respective secondary antibodies conjugated to DylightTM-649 (Jackson Immunoresearch,
West Grove, PA) at 1:1000 dilution and mounted with Fluormount-GTM 22-20,
(SouthernBiotech, Birmingham, AL) containing 4',6-diamidino-2-phenylindole (DAPI)
for nuclear staining. Fluorescently labeled cells were analyzed as described8 using the
Axioplan 2 imaging system (Carl Zeiss Microimaging, Inc., Thornwood, NY) equipped
with a ORCA-ER CCD camera (Hamamatsu Photonics, Japan) coupled with a Lambda
DG-4 wavelength switch (Sutter Instrument, Novato, CA) and acquisition software
SlidebookTM 5 (Intelligent Imaging Innovations, Inc., Denver, CO). p53-positive and
acetyl-p53-positve cells were quantified by counting at least 400 cells/well with n ≥ 4 for
each treatment by a person unaware of the treatment groups.
Adenoviral Overexpression
Adenovirus expression vectors for p53 were developed by cloning p53 cDNA into
the shuttle vector. Shuttle CMV_p53 was packaged into virus-producing cells, and
adenovirus particles were harvested as described 23.
Bmf mRNA Half-life
Cells were treated with the RNA polymerase inhibitor 5,6-dichloro-1-beta-Dribobenzimidazole (DRB) (Sigma-Aldrich, St. Louis, MO) at a final concentration of 50
ng/ml for SAOS-2, Calu-3, A549, and Calu6, and at 100ng/ml for AALEBs to stop RNA
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polymerase activity. The relative mRNA abundance was calculated using the ∆∆Ct
method, and the mRNA half life was calculated using Greenberg formula 24.
Chromatin Immunoprecipitation
After treating with 50 ng/ml hrIFNγ for 48 h, cells were fixed with 1%
formaldehyde; the reaction was quenched using 1.25 M glycine and scraped into cold
PBS-containing protease inhibitors. Chromatin immunoprecipitation was performed
using the MAGNA0002 Magna ChIP G kit (Millipore, Billerica, MA) as described by the
manufacturer. Sonicated nuclear fractions were incubated with mouse IgG1 monoclonal
antibody to p53 (Santa Cruz sc-98 Pab1801), rabbit polyclonal antibody to HDAC1 (06720 Millipore), rabbit polyclonal antibody to acetyl H4 (06-598 Millipore), rabbit
polyclonal antibody to acetyl H3 (06-599B Millipore), mouse IgG1, or rabbit as control
(CBL600 Millipore). DNA identification was confirmed with PCR using the following
primers specific for the Bmf promoter at region -560 5’ACCTAAGGGCTCCCCTGGA3’, 5’-GCAGGTCGGAAGAAAACTGCAGC-3’, and region -97 5’TTGGCGCTTCACTCGCCATT-3’, 5’-ATCCCGCAAACAGCTGAT-3’.
Immunoprecipitation
Cells were treated with IFNγ for 48 h, fixed, rinsed twice with cold PBS, and
scraped in cold PBS plus protease inhibitors. Immunoprecipitation was performed using
the Pierce Crosslink IP Kit (26147) as described by the manufacturer.
Immunoprecipitated proteins from nuclear extracts were analyzed by Western blotting for
HDAC1, anti-p53 (FL-393 Santa Cruz), and acetyl-p53 (Lys382) (#2525 Cell Signaling,
Inc., Boston, MA).
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Statistical Analysis
Fold changes or scanned density values were averaged and compared for
significance between groups using Student’s t-test. Data were analyzed using Prism
statistical analysis software, and p< 0.05 was considered statistically significant.
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2.4 Results
Our previous studies demonstrate that physiological relevant levels of IFNγ
induce cell death in primary normal human airway epithelial cells (HAECs), murine
airway epithelial cells (MAECs), and AALEB cells, a cell line derived from HAECs 7, 8.
IFNγ-induced cell death is mediated by STAT1-dependent Bik expression 6. While
screening for the effect of IFNγ on the expression of BH3-only proteins, we found that
IFNγ reduced Bmf mRNA levels in AALEB cells by 5-fold over 24 h (Figure 2-1A), and
this reduction was replicated in both HAECs (Figure 2-1B) and MAECs (Figure 2-1C).
Western blot analysis also showed that Bmf protein is reduced at 48 h of IFNγ treatment
in MAECs; this protein is 30 kDa in size and represents likely the Bmf II 25 (Figure 21D). Treatment of STAT1-/- (Figure 2-1E), bik-/-(Figure 2-1F), or wild-type MAECs with
IFNγ also reduced Bmf mRNA levels suggesting that downregulation of Bmf was
independent of IFNγ activating STAT1 or Bik expression.
To further investigate this unexpected finding, we explored the effect of IFNγ on
Bmf mRNA levels in epithelial cell lines derived from various cancers as previous
studies have described Bmf expression in cancer cell lines10, 13. This analysis uncovered
a striking correlation between basal Bmf mRNA expression levels and p53 status. The
p53-deficient cell lines SOAS-2 and Calu-6 cells showed significantly higher Bmf
mRNA levels compared to the p53-sufficient cells, A549, and AALEB cells (Figure 22A). The role of p53 in affecting Bmf expression was validated by expressing p53 in
Calu-6 cells using an adenoviral overexpression system (Figure 2-2B). Interestingly, p53
expression alone was not sufficient; additional treatment with 10 mJ UV light was
necessary for reducing Bmf levels, while the same treatment significantly increased Bmf
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mRNA levels in cells infected with adenoviral GFP as control (Figure 2-2C). Identical
results were obtained when p53 was expressed in Calu-6 cells using a lentiviral
expression system after treatment with UV light (data not shown). Consistent with
previous reports, exposure of MAECs to 10 mJ of UV light increased p53 levels (Figure
2-2D) and reduced Bmf mRNA levels to 50% of non-treated controls in both MAECs
(Figure 2-2E) and AALEB cells (Figure 2-2F) 6 h after treatment.
Previous reports have established that HDAC1 suppresses Bmf expression by
inhibiting the promoter activity 17. Therefore, we wanted to investigate whether HDACis
affect Bmf expression in a p53-dependent manner. The HDACis, sodium butyrate, TSA,
or MS-275 significantly increased Bmf mRNA levels in AALEB cells (Figure 2-3A), and
TSA increased Bmf protein levels in MAECs (Figure 2-3B). While Bmf mRNA levels
were increased by TSA in both p53-/- and p53+/+ MAECs, Bmf mRNA expression was 2fold higher in p53-/- compared to p53+/+ MAECs (Figure 2-3C) suggesting that the
inhibitory role of p53 may be independent of the regulation by HDACs.
These findings showed that IFNγ may affect p53 to cause the reduction of Bmf
expression. Therefore, we investigated the effect of IFNγ on primary MAECs from p53-/and p53+/+ mice and found that Bmf mRNA levels were significantly increased by IFNγ
in p53-/- MAECs (Figure 2-4A). Furthermore, Bmf protein was detected in IFNγ-treated
p53-/- but not p53+/+ MAECs (Figure 2-4B). Similarly, suppression of p53 levels in
AALEB cells using shRNA resulted in IFNγ failing to suppress Bmf mRNA levels (data
not shown).
Having established that p53 suppresses Bmf expression, we investigated the
possibility that p53 may affect Bmf mRNA stability. The Bmf mRNA has an unusually
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long 4kb 3’UTR indicating that it may be a crucial factor in regulating expression levels.
In general, 3’UTRs have conserved sequences that regulate mRNA stability 26. For these
studies, transcription was blocked with DRB, and cells were harvested at 0, 0.5, 1, 2, and
4 h with or without IFNγ treatment. On average, the half-life of Bmf mRNA in nontreated, p53-sufficient A549 and AALEB cells was 1.94 and 2.43, respectively, and in the
p53–deficient Calu-6 and SAOS cells, 2.36 and 1.73, respectively. Bmf mRNA half-life
in IFNγ-treated, p53-sufficient and p53-deficient cells was 1.5 and 1.8 h, respectively.
These data suggest that p53 did not affect Bmf mRNA stability.
Because IFNγ did not affect Bmf mRNA half-life, we next evaluated whether
IFNγ affects the interaction of p53 with the Bmf promoter. The -97 region was
responsible for acetylation in cancer cell lines in response to HDACi treatment 17.
Therefore, we selected the -97 region to test for p53 interaction. The -560 region was
selected as an additional region assuming that there would be less acetylation activity
than the -97 region yet strong HDAC1 interaction. ChIP assays showed that p53
interacted with the Bmf promoter only in IFNγ-treated AALEB cells but not in nontreated controls (Figure 2-5A). This interaction was observed only for the region close to
the transcriptional start site at -97, while no interaction was observed at -560. To further
investigate the IFNγ-induced modification on p53, we analyzed the distribution of p53 in
the cytosolic and nuclear fractions, and found that nuclear p53 levels were greater in
IFNγ-treated AALEB cells compared to non-treated controls (Figure 2-5B). Similarly,
MAECs showed increased p53 levels in the IFNγ-treated cells (data not shown).
Increased nuclear localization of p53 in IFNγ-treated cells was also observed by
immunofluorescence (Figure 2-5C), thus confirming the findings by Western blotting.
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Together, these studies showed that IFNγ treatment modified p53 causing nuclear
accumulation of this protein.
In humans, the proline-rich domain of p53 (PRD) is defined by residues 58–98
that contains 15 prolines and five repeats of the amino acid motif PXXP (where P
designates proline and X any amino acid). The histone acetyl transferase p300 binds to
PXXP-containing peptides derived from the proline repeat domain, and the PXXP motif
in p53 is required for p53 acetylation 27. Therefore, we investigated whether this region
plays a role in the IFNγ-induced Bmf suppression. In mice, this PRD consists of two
PXXP motifs, and we obtained mice with a deletion of the PRD (p53ΔP) or lacking the
four critical proline residues at loci 79, 82, 84, and 87 that make up the tandem PXXP
sites (p53AXXA) 28, 29. MAECs isolated from p53ΔP, p53AXXA, and wild-type littermates
were treated with IFNγ and analyzed for Bmf levels, which were reduced in these cells as
was observed in wild-type MAECs (Figure 2-5D) suggesting that this region is not
crucial for the modification in p53 to be enriched in the nucleus.
The stability of p53 is regulated primarily by the E3 ubiquitin-ligase activity of
Mdm228, and phosphorylation of p53 disrupts interactions between p53 and Mdm2
leading to p53 stabilization 30. Nutlin-3, a synthetic cis-imidazoline anolog specifically
blocks the interaction between p53 and Mdm2 by interacting with a large hydrophobic
pocket in the Mdm2 protein which p53 occupies. This results in the stabilization of p53,
enhancing p53 activity, such as induction of apoptosis and cell cycle arrest of cancer
cells. Numerous studies showed that nutlin-3 is very specific for Mdm2; in addition,
experiments using the enantiomer of nutlin 3 as a control determined that the enatiomer is
150 times less active and does not cause stabilization of p53 31. Bmf mRNA levels were
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induced in AALEB cells treated with nutlin-3 for 24 h compared to untreated cells
(Figure 2-5E), or remained unchanged in the MAECs (data not shown). In a separate set
of studies, AALEB cells were treated with nutlin, nutlin and IFNγ, and nutlin and UV
light to examine whether nutlin treatment affects the suppression of Bmf mRNA when
p53 was modified by these cell death-inducing stimuli. Interestingly, the disruption of
p53 from Mdm2 by nutlin3 did not affect suppression of Bmf expression in response to
IFNγ or UV light treatment (Figure 2-5F). These findings suggested that p53 must have
been modified in a different manner from the disruption from Mdm2 interaction.
Several of our findings suggest that modification of p53 by IFNγ may involve
acetylation. First, the effect of HDACis on Bmf expression is suppressed by p53 and
second, Bmf promoter is known to interact with HDAC117. Therefore, we performed
immunoprecipitation assays using anti-p53 antibodies and analyzed the pull-down
products for HDAC1 and total p53. HDAC1 levels were increased in pull-down products
from IFNγ-treated cells compared to non-treated cells (Figure 2-6A) suggesting that IFNγ
enhanced the p53/HDAC1 interaction. Because p53 was found to be complexed with a
histone deacetylase we were interested in assessing the acetylation state of p53 after IFNγ
treatment. Immunoblotting of the pull-down product using antibodies specific to
K382p53 revealed that acetylated p53 levels were significantly reduced in IFNγ-treated
compared to non-treated cells (Figure 2-6A). These results suggest that the IFNγ-induced
interaction of HDAC1 and p53 may have resulted in the deactylation of p53. The fact
that IFNγ treatment leads to deacetylation of p53 was also observed in MAECs as the
cytosolic nuclear p53 showed reduced acetylation in IFNγ- compared to non-treated
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controls (Figure 2-6B). This finding was confirmed by immunostaining of IFNγ-treated
MAECs and controls using antibodies specific to acetyl p53 (Figure 2-6C).

2.5 Discussion
The present studies show that IFNγ promotes p53/HDAC1 interaction,
deacetylates p53, and enhances p53 to interact with the Bmf promoter and suppress
expression. In addition, this suppressive effect of p53 on Bmf expression occurred when
cells were exposed to other cell death-stimulating agents including UV light and
HDACis.
Suppression of Bmf occurred within 6 h of treatment with UV light but 48 h after
IFNγ treatment. These findings suggest that the IFNγ-induced deacetylation of p53 may
be mediated by events triggered at later time points; however, to our knowledge, the fact
that IFNγ modifies p53 has previously not been reported. Both STAT1 and Bik or
merely disruption of the p53-Mdm2 interaction with nutlin 3 32 were not sufficient to
modify the reduction of Bmf expression. In addition, AECs with either deleted PRD or
mutations of the proline residues within the PRD of p53 to alanines did not abrogate the
IFNγ-induced downregulation of Bmf demonstrating that the IFNγ-induced deacetylation
must occur at sites other than the proline-rich domain (PRD). Downregulation of Bmf by
IFNγ was also observed in NHBEs that were derived from 3 individuals each that had the
Arg/Arg or the Pro/Pro p53 genotype at codon 72 within the PRD (data not shown) that
corresponds to the mouse PXXP motif, further supporting the idea that the PRD is not
involved in the IFNγ-induced modification of p53 and suppression of Bmf expression. In
addition, merely increasing p53 expression using an adenoviral or lentiviral expression
vectors was not sufficient but treatment with UV light of p53-expressing Calu-6 cells was
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necessary to suppress Bmf levels. While p53 can be increased in level due to
stabilization in response to the p53-Mdm2 feedback loop, our findings suggest that p53
must undergo posttranslational modifications acetylation/deacetylation to be activated 33.
The effects of IFNγ on signaling kinase ERK in AECs has been demonstrated 6.
However, blocking the activation of ERK1/2 using UO126 did not affect IFNγ-induced
deacetylation of p53 (data not shown). Therefore, the pathway by which IFNγ causes
deacetylation and nuclear accumulation of p53 remains to be elucidated.
At least three independent pathways activate the p53 network. The first pathway
is triggered by ionizing irradiation causing double strand breaks that is recognized by the
Ataxia telangiectasia mutated (ATM), Chk2 pathway 34, the p14ARF pathway, and the
ATR (ataxia telangiectasia related) and casein kinase II that involves kinases 35. Many
other genes have been reported to be suppressed by p53 including DNA topoisomerase II,
cyclin B, Cdc2 36, MMP-1 and -13 37, presenilin-1 38, myc, and Map-4 39. In general,
transcriptional activation requires p53 to bind a consensus sequence 40; however, the
repression mechanism by p53 is not well studied. For example, p53 directly binds to the
Mad1L1 promoter, but no p53 consensus site was found 41. Similarly, we found that p53
interacts with the Bmf promoter when cells are treated with IFNγ, although a consensusbinding sequence for p53 was not found in the upstream region of the bmf gene. While
DNA binding is required for p53 to suppress cdc2 36 or cdc20 42, p53 can also suppress by
interfering with transcriptional factors, which usually transactivate the genes 43.
We found that HDACis consistently induced Bmf expression in primary human
and mouse airway epithelial cells. However, extent of induction was suppressed in the
presence of p53. These findings suggested that induction of Bmf is independently
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regulated by histone acetylation and by p53 deacetylation. The fact that p53 dampens
HDACi-induced Bmf expression further supports our findings that deacetylated p53
interacts with the Bmf promoter to suppress its activity. Similar to our findings, the
HDACis induce acetylation of histones H3 and H4 at the Bmf promoter region in various
human cancer cell lines and HDAC1 expression reduces Bmf expression 17. The previous
studies also showed that overexpression of histone acetyltransferase p300 mimics the
effects of the HDAC inhibitors, suggesting that Bmf expression in cancer cells is
primarily regulated by histone hyperacetylation 44, and this approach was the basis to
promote HDACis for cancer therapy. However, our findings that these agents also
induce Bmf in primary airway epithelial cells may suggest side effects and that the use of
these compounds for cancer therapy should be approached with caution.
Because IFNγ treatment or the presence/absence of p53 had no effect on Bmf
mRNA half-life and results from ChIP assays showed that IFNγ modified the interaction
of p53 with the Bmf promoter it is likely that p53 and HDAC1 affect promoter activity by
affecting chromatin remodeling. Because HDAC1 associates with the Bmf promoter in
an untreated condition 44 and p53 deacetylation correlates with the increased interaction
of p53 with HDAC1 we conclude that IFNγ treatment causes the deacetylation likely by
promoting p53/HDAC1 interaction. While the modification of p53 by HDACis has been
studied in lung cancer cells 18, the state of p53 acetylation in airway epithelial cells has
not been studied. Interestingly, acetylated p53 was present in non-treated cells
suggesting that acetylated p53 may be crucial for the regular proliferation of HAECs and
MAECs.
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IFNγ caused deacetylation and nuclear accumulation of p53 suggesting that
acetylation may be involved in the proper transport of p53 out of the nucleus. When p53
is acetylated on the 8 lysine residues in the DNA binding and C-terminal regions the
interaction with Mdm2 is prevented leading to stabilization and increase in p53 protein 33.
Marchenko et al. report that the classic importin-α/β pathway is responsible for import of
only non-ubiquitinated p53 into the nucleus during the early stages of stress response
such as DNA damage 45. Future studies will investigate the lysine residues that are
deacetylated by IFNγ and whether this modification minimizes the interaction of p53
with nuclear export proteins such as MDM2-mediated ubiquitination 46 to increase
nuclear p53 levels.
The fact that p53 mediates the IFNγ-induced Bmf suppression in HAECs and
MAECs suggests that p53 is not involved in the IFNγ-induced cell death pathway. This
hypothesis is supported by our previous studies demonstrating that IFNγ induces Bik
expression in p53+/+and p53-/- MAECs and causes cell death in a p53-independent
manner 6 and that p53 levels remain unaffected by IFNγ 8. Bmf (Bmf I) has a proapoptotic function, while Bmf II and Bmf III have functions contributing to survival and
growth 25. Western blot analysis showed that a 30kDA Bmf protein was reduced by IFNγ
treatment that corresponds to the Bmf II, a protein that in contrast to the Bmf-I had no
effect on apoptosis and instead increased colony formation 25. Therefore, we conclude
that IFNγ by suppressing the isoform that enhances colony formation enhances the effect
of Bmf I to enhance the cell death pathway. Bmf I is a pro-apoptotic protein 13, 11 and its
localization determines its role to induce cell death 10. Therefore, functional studies on
the possible translocation of Bmf I in IFNγ-induced cell death are in progress.
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2.6 FIGURES AND LEGENDS

Figure 2-1. IFNγ down regulates Bmf expression.
Bmf mRNA levels were quantified by qRT-PCR in A) AALEB cells, B) HAECs, C)
wild-type MAECs E) STAT1-/- MAECs, or F) Bik-/- MAECs after treatment with IFNγ (50
ng/ml) and harvested at indicated time points or at 48 h when not stated in the figure. D)
Bmf protein levels in lysates of MAECs treated with IFNγ for 48 h. The relative standard
curve method was used for analysis of unknown samples, and data are presented as fold
change after averaging the ∆CT values for the untreated samples. Data presented are
means ± SEM for three independent experiments. * P<0.05; statistically significant
difference from the untreated control.
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Figure 2-2. Bmf expression is suppressed by p53.
A) Bmf expression levels in p53-sufficient and -deficient cell lines were evaluated using
qRT-PCR; Bmf mRNA levels relative to p53-sufficient A549 are shown for AALEB
cells, along with p53-deficient SAOS-2 and Calu-6 cells. B) Western blot analysis of p53
in Calu-6 cells infected with an adenoviral expression vector for p53. C) Relative Bmf
mRNA levels quantified by qRT-PCR in Calu-6 cells infected with an adenoviral
expression vector for GFP or p53 and exposed to 10 mJ of UV light compared to the
respective non-treated controls. D) p53 protein levels in MAEC lysates 6 h after
exposure to 10 mJ of UV light. E) MAECs exposed to10 mJ of UV light and analyzed
for Bmf mRNA 6 h after exposure to 10 mJ of UV light compared to non-treated
controls. F) AALEB cells exposed to10 mJ of UV light and analyzed for Bmf mRNA 6,
12, and 24 h after exposure compared to non-treated controls. Data presented are means
± SEM for three independent experiments. * P<0.05; statistically significant difference
from the control.
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Figure 2-3. p53 suppresses HDACi-induced increase in Bmf mRNA and protein
levels.
A) Bmf mRNA levels in AALEB cells treated with 5 mM sodium butyrate, 300 nM TSA,
and 5 µM of MS-275 for 18 h compared to non-treated controls. B) Bmf mRNA
expression in p53-/-and p53+/+MAECs treated with 300nM TSA for 18 h. Error bar
indicates ± SEM. *, P<0.05; statistically significant difference from the control.
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Figure 2-4. IFN-γ induces Bmf mRNA and protein expression in p53-deficient
MAECs.
A) Bmf mRNA in IFNγ-treated and non-treated p53-/- MAECs. Error bar indicates ±
SEM. *, P<0.05; statistically significant difference from the control. B) Bmf protein
levels in p53-/-and p53+/+ MAECs treated with nothing or IFNγ for 48 h.
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Figure 2-5. p53 is enriched in the nucleus and interacts with the Bmf promoter.
A) ChIP assays performed on AALEB cells treated with IFNγ for 48 h using a
monoclonal antibody to p53 or mouse IgG1 as control. DNA was identified using PCR
with primers specific for Bmf promoter regions at -97 or -560 regions. Densitometry was
used to quantify the amount of DNA in the PCR products from six independent
experiments. Quantification of the DNA associated with p53 was normalized to IgG1,
and IFNγ-treated values were normalized to the untreated values. B) Increased p53
protein levels in the nuclear fractions of AALEB cells 48 h after treatment with IFNγ
compared to non-treated controls. Nuclear and cytosolic extracts were analyzed for p53,
lamin, and actin. Figure is representative of three independent experiments. C)
Immunostaining of AALEB cells treated with IFNγ for 48 h with anti- p53 antibody and
quantification of p53-positive nuclei. D) Bmf mRNA levels in MAECs isolated from
p53ΔP and p53AXXA and wild-type littermate mice. E) Bmf mRNA levels in AALEB cells
treated with Nutlin 3 for 24 h. F) Bmf mRNA levels in AALEB cells treated with nutlin
3 and then treated with IFNγ for 48 h or exposed to UV for 6 h and compared to their
respective untreated control.
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Figure 2-6. IFNγ deacetylates p53.
A) HDAC1 interacts with p53. Nuclear lysates were prepared from AALEB cells after
treatment with IFNγ for 48 h and were immunoprecipitated using a p53-specific
monoclonal antibody. The nuclear lysates (input) and immunoprecipitates were resolved
by SDS PAGE and analyzed using Western blotting using antibodies to HDAC1, total
p53, and acetyl p53. B) Nuclear extracts prepared from IFNγ-treated and non-treated
MAECs and probed for total p53, acetyl p53, and lamin. C) AALEB cells treated with
IFNγ for 48 h immunostained with anti-acetyl p53 and quantified.
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Chapter 3
IFNγ Inhibits HDAC1 and Induces Expression of Bmf
to Reduce Allergen-Induced Mucous Cell Metaplasia
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3.1 ABSTRACT
Reports show that histone deacetylase 2 (HDAC2) levels are reduced in macrophages
and other inflammatory cells of patients with severe asthma and COPD, and that HDAC2
suppresses expression of inflammatory genes. However, the role of HDACs in airway
epithelial cells and how they affect epithelial cell hyperplasia (ECH) is unknown. Our
previous studies have shown that the resolution of MCM during prolonged exposure to
allergen is mediated by IFNγ through STAT1-mediated effect on the Bcl-2 family of
proteins. In cancer cells, Bmf, a pro-apoptotic member of the Bcl-2 family, is suppressed by
HDAC1 and histone modifications. Therefore, we investigated the role of HDACs and Bmf
in regulating airway epithelial cell death and ECH. We found that various HDAC inhibitors
including sodium butyrate, trichostatin A1, and MS-275 induce Bmf expression not only in
cancer cells but also in primary mouse airway epithelial cells (MAECs) and in an
immortalized airway epithelial cell line (AALEB cells). Chromatin immunoprecipitation
(ChIP) assays demonstrated that TSA enhanced acetylation of histones 3 and 4 but reduced
the association of HDAC1 with the Bmf promoter in AALEB cells. MAECs from bmf-/- but
not bmf+/+ mice were protected from TSA-induced cell death and restoring Bmf using an
adenoviral overexpression system (Ad-Bmf) in bmf-/- MAECs restored TSA-induced death.
Bmf expression was increased in hyperplastic epithelial cells of mice exposed to allergen for
prolonged periods, and MCM was resolved, while resolution of MCM was abrogated in bmf/-

mice. IFNγ blocked HDAC1 interaction with the Bmf promoter in airway epithelial cells.

Together, these findings suggest that the resolution of allergen-induced MCM is mediated
by IFNγ disrupting HDAC1 interaction with the Bmf promoter and inducing expression of
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this pro-apoptotic protein. These findings suggest that inhibitors specific for HDAC1 may
be useful to reduce MCM in asthma and COPD.
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3.2 INTRODUCTION
The transfer and removal of acetyl groups from proteins and lysine residues of
histones is a critical factor in the regulation of cellular functions and is regulated by
histone acetyltransferases (HATs) and histone deacetylases (HDACs)2. HDACs are
targets for cancer and chronic disease therapies because of their important role in the
transcriptional control of large numbers of genes, that may be aberrant in tumors or
chronic disease3. Histone deacetylase inhibitors (HDACis) inhibit HDACs causing
changes in gene transcription. Trichostatin A1 and Na-Butyric acid are pan-HDAC
inhibitors meaning that they inhibit all three classes of HDACs4 while more recently MS275 and FK228, class-specific HDACis, have been developed with the goal of increasing
specificity and reducing toxicity 3.
HDAC2 mRNA levels are reduced in the bronchial biopsies and alveolar
macrophages of patients with severe asthma and COPD 5. HDAC2 is also reported to
suppress the expression of inflammatory genes. Furthermore, HAT activity is increased
in the bronchial biopsies from the severely asthmatic population. These observations
suggest that histone modification play a role in the regulation of inflammatory conditions
of the lung 5.
Aerosol exposure of mice to allergen is an in vivo approach to studying a major
characteristic of human allergen-induced asthma. Exposure of ovalbumin-immunized
mice to ovalbumin aerosols elicits allergic airway inflammation that causes epithelial cell
hyperplasia and mucous cell metaplasia (MCM); as a result of prolonged exposure,
hyperplastic AECs and mucous cells are removed via IFNγ -induced cell death6.
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The resolution of MCM is regulated by cell death regulator proteins that belong to
the Bcl-2 family 7. Bcl-2 homology (BH) regions characterize proteins from this family,
Bcl-2, Bcl-xl, and Mcl-1 have four BH regions and carryout an anti-apoptotic function,
while Bax and Bak with three BH regions are pro-apoptotic 8. BH3 domain-only proteins
as their name so implies possess one BH region, and include Bik, Bmf, Noxa, Puma,
Bim, and others 9. Interaction between anti-apoptotic and pro-apoptotic members is
critical for apoptosis to occur 8. A cell type specific function has been reported for many
of the BH3-only proteins. For instance, BH3-only Bik was dispensable for cell death in
cells of the hematopoietic compartment10, but is a critical mediator of IFNγ-induced AEC
death 11. Bik is critical for the IFNγ-induced resolution of MCM, as this process is
disrupted in the bik-/- mice 11. Pro-apoptotic Bax is also important for IFNγ-induced cell
death; it translocates to the ER, resulting in the release of calcium stores. Resolution is
delayed in bax-/- mice12, demonstrating that Bax is also an important protein for the
resolution of MCM.
In gastric carcinoma cell lines, pro-apoptotic BH3 domain-only Bmf has been shown
to be important for cell death in response to the HDACis, FK228, and CBHA. In these cells,
Bmf expression is increased as a result of increased acetylation of the histones H3 and H4 at
the Bmf promoter 13. While Bmf-deficient thymocytes and pre-B cells are undergoing
apoptosis in response to the HDACi SAHA, they are not resistant to the other HDACis TSA
or CBHA14. These results are indicative of different types of HDACs playing a role in Bmfinduced cell death.
Our findings suggest that AECs are very sensitive to pan-HDAC inhibitors, such as
TSA and Na-Butyric acid, while slightly less sensitive to class I-specific MS-275. In AECs
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we find that Bmf is strongly induced by HDACis through the displacement of HDAC1 from
its promoter and is directly responsible for cell death in response to TSA.
Studies suggest that Bmf is sequestered to the DLC of the cytoskeleton and released
in response to cellular stressors causing detachment-induced cell death in MEFs 15.
Translocation to the mitochondria is said to follow release from the cytoskeleton 15. Further
studies in Bmf-deficient mouse embryo fibroblasts and gastrointestinal epithelial cells did not
support a critical role for Bmf during anoikis 14. However, Bmf as a sensitizer to anoikis was
reported in mammary epithelial cells 16.
Because preliminary microscopic studies suggest that hyperplastic AECs detach
from the basement membrane during resolution (unpublished), and previous studies
suggested that Bmf is important for detachment-induced cell death, we investigated whether
Bmf is involved in the IFNγ-induced resolution of MCM. The present report shows that
Bmf mediates HDACi-induced cell death in AECs, IFNγ displaces HDAC1 from the Bmf
promoter, and Bmf mediates IFNγ-induced cell death. In addition, we show that Bmf is
important for the resolution of MCM in the mouse model of asthma.
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3.3 EXPERIMENTAL PROCEDURES
3.3.1. Cell Culture
The preparation of MAECs was carried out as described11. The immortalized
human airway epithelial cells, AALEB cells 17 were maintained in bronchial epithelial
medium (BEGM, Lonza, Walkersville, MD)
3.3.2 Animals
Pathogen-free bmf-/- on the C57BL/6J background were a gift from A. Strasser
(Walter and Eliza Hall Institute, Melbourne Australia). The bmf-/-and wild-type
C57BL/6J mice were bred at the Lovelace Respiratory Research Institute (LRRI) under
specific pathogen-free conditions and genotyped as described 18. All animal experiments
were approved by the Institutional Animal Care and Use Committee. LRRI is a facility
approved by the Association for the Assessment and Accreditation for Laboratory
Animal Care International. Sensitization and exposure of 8-10 wk old mice to ovalbumin
was performed as described 12. Preparation of lung tissues for histopathological
examination and staining with Alcian blue and periodic acid Schiff or hematoxylin and
eosin as described 6. The number of Alcian blue-positive cells per millimeter of basal
lamina was quantified using a light microscope (BH-2; Olympus) equipped with the
Image analysis system (National Institutes of Health) as described 19.
3.3.3 Immunohistochemistry
Lung tissue sections were deparaffinized, rehydrated, washed, and after antigen
retrieval incubated with monoclonal rat anti-mouse Bmf (17A9 a gift from A. Strasser,
Walter and Eliza Hall Institute, Melbourne, Australia) primary antibody at 1:500 dilution
and anti-rat secondary antibody as described 20. Immunohistochemical stains were

	
  

49

imaged using a microscope (Eclipse E600W; Nikon) with a Plan Fluor 60x NA 0.85
objective and a digital camera (DXM1200F; Nikon) with ACT-1 acquisition software
(version 2.62l Nikon)
3.3.4 Laser Capture Microdissection
While the left lungs were sectioned for histological analysis, the right lungs of
these animals were use for laser capture microdissection (LCM). Right lungs from
exposed animals were inflated by carefully injecting OCT (1:4 dilution in PBS) into the
large airway, embedded in OCT, and snap frozen. Tissues were cryosectioned and
prepared as is described in the manufacturer’s protocol. AECs from five large airways
were captured using a laser onto CapSure HS LCM Caps (Arcturas MDS Analytical
Technologies, Sunnyvale, CA) using the Arcturus system (Arcturus, Bioscience, Inc.
Mountain View, CA). Cellular lysate was extracted from the cap using the PicoPure
RNA Isolation Kit as described by the manufacturer (Arcturas, Bioscience, Inc.).
3.3.5 mRNA Extraction and Analysis
The RNeasy kit (Qiagen, Valencia, CA) was used for the extraction of RNA from
cell pellets, and concentration was determined using the Thermo Scientific Nanodrop
1000 Spectrophotometer (Thermo Fisher Scientific, Waltham, MA). The primer/probe
sets for Bad, Bak, Bax, Bcl-2, Bcl-xL, Bik, Bmf, CDKN1B, Muc5ac, Noxa, and Puma
were obtained from (Applied Biosystems, Foster City, CA). Target mRNAs were
amplified by quantitative real-time PCR in 20 µl reactions on the ABI PRISM 7900HT
Real-Time PCR System using the One-Step RT-PCR Master Mix (Applied Biosystems).
Relative quantities from duplicate amplifications were calculated by normalizing
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averaged CT values to CDKN1B to obtain ∆CT, and the relative standard curve method
was used for determining the fold change as described 21.
3.3.6 Western Blot
Total protein lysates were prepared using RIPA buffer (10 mM Tris, pH 7.4, 15
mM NaCl, 1% Triton X-100, 0.1% SDS, 5 mM EDTA, and protease inhibitors). For
histone extraction experiments, lysates were prepared as described 22. Protein
concentration was determined by BCA kit (Pierce, Rockford, IL), and 25 µg of protein
lysate were analyzed by Western blotting as described 17. We used the rat anti-Bmf 17A9
monoclonal antibody, a gift from Dr. Andreas Strasser (the Walter and Eliza Hall
Institute of Medical Research, Melbourne, Australia) at 2 µg/ml. Mouse anti-actin
polyclonal antibody (Santa Cruz Biotechnology, Inc.) was used at 1:5000. Goat anti-rat
and rabbit anti-mouse secondary antibodies were used for visualizing proteins with
chemiluminescence reagents (Perkin Elmer, Waltham, MA) using FujiFilm Image Reader
LAS-4000 (Valhalla, NY).
3.3.7 Chromatin Immunoprecipitation
After treating with 300 nM of TSA or 50 ng/ml hr IFNγ for 18 or 48 h,
respectively, cells were fixed with 1% formaldehyde, the reaction quenched using 1.25 M
glycine, and scraped into cold PBS-containing protease inhibitors. Chromatin
immunoprecipitation was performed using the MAGNA0002 Magna ChIP kit (Millipore,
Billerica, MA) as described by the manufacturer. Sonicated nuclear fractions were
incubated with polyclonal antibodies to acetyl H3 (06-599B Millipore), acetyl H4 (06598 Millipore), rabbit polyclonal antibody to HDAC1 (06-720 Millipore), and rabbit IgG
as control. DNA identification was confirmed with PCR using the following primers
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specific for the Bmf promoter at region -560 5’-ACCTAAGGGCTCCCCTGGA-3’, 5’GCAGGTCGGAAGAAAACTGCAGC-3’, and region -97 5’TTGGCGCTTCACTCGCCATT-3’, 5’-ATCCCGCAAACAGCTGAT-3’.
3.3.8 Quantitative Analysis of Apoptosis
Cells treated in 6-well tissue culture plates as described earlier were harvested
using cold Trypsin-EDTA, washed twice in cold PBS, and resuspended in staining buffer
(10 mM HEPES, 0.14M NaCl, 2.5 mM CaCl2, pH 7.4). Double staining with FITCAnnexin V and Propidium Iodide (PI) was carried out according to the manufacturer’s
recommendations and then analyzed by FACS to quantitate early apoptotic cells
(Annexin V+, PI-) and late apoptotic cells (Annexin V+, PI+).
3.3.9 Adenoviral Expression
RNA (1µg) extracted from AECs using The RNeasy kit (Qiagen, Valencia, CA)
was reverse transcribed using oligo (dT) primers. The following primers were used for
PCR, 5’-AGGTACCCCACCATGGAGCCACCTCAGTGTG-3’ and 5’AGTCTAGATCACACAGGGCCCCACCCCTTC-3’. PCR was performed using the
following conditions: 30 cycles of 94°C for 1 min, 55°C for 1 min, and 72°C for 2 min.
Bmf and GFP cDNAs were subcloned into the adenovirus expression shuttle vector.
Shuttle CMV_Bmf and Shuttle CMV_GFP were packaged into virus-producing cells, and
adenovirus particles were harvested as described 23.
3.3.10 Statistical Analysis
Fold changes, scanned density values, or differences in cell numbers between two
groups were averaged and compared for significance between groups using Student’s t-
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test. Data were analyzed using Prism statistical analysis software, and p<0.05 was
considered statistically significant.
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RESULTS 3.4
3.4.1 Histone deacetylase inhibitors (HDACis) induce Bmf expression through
increasing histone acetylation and displacement of HDAC1.
Based on previous reports in gastric carcinoma cell lines that Bmf is induced by
the HDACi FK228 acetylating histone tails on the promoter region, we examined
whether methylation or acetylation caused induction of Bmf mRNA in lung cancer cell
lines. H1568, H2023, and H2228 cell lines treated with TSA showed a strong induction
of Bmf mRNA (Figure 3-1A), while the methylation agent 5-aza-2′ deoxycytidine
(decitabine, DAC) produced no change in mRNA levels (data not shown). To determine
whether this induction is specific to cancer cell lines only, we tested whether primary
MAECs reacted to TSA in a similar fashion and found that both Bmf mRNA and protein
were induced in response to TSA (Figure 3-1B). Experiments that looked at global
acetylation levels of histone 4 in histone-containing lysates extracted from TSA-treated
AALEBs showed dramatic increases of acetylated histone 4 (Figure 3-1C). ChIP assays
confirmed the acetylation of histones H3 and H4 and the association of HDAC1 at the
Bmf promoter. Primer sets were designed for DNA identification to span two different
100 base pair regions of the Bmf promoter, 97 base pairs and 560 base pairs upstream
from the start site. We found that the acetylation levels of both histone 3 and histone 4
are increased in response to TSA treatment, and that that TSA diminished the interaction
of HDAC1 with both of the Bmf promoter regions (Figure 3-1D).
3.4.2 Expression of pro-apoptotic Bmf induces apoptosis in AECs.
Because Bmf has a pro-apoptotic function 24 and HDACi-induced cell death was
mediated by Bmf in B cells 14, we were interested to see if Bmf mediates HDACi-induced
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cell death in AECs. AALEB cell numbers were reduced by 30-50% when treated with
various HDACis including TSA, sodium butyrate, and MS-275 (Figure 3-2A). Reports
that Bmf is a sensitizer to cell death but cannot induce it on its own16 led us to test
whether Bmf is pro-apoptotic in AECs. We developed an adenoviral expression vector
(Ad-Bmf) (Figure 3-2B) and infected primary MAECs with Ad-Bmf and Ad-GFP at 50
MOI; this MOI was selected because expressed levels reproduced the level of Bmf
expression that results from TSA treatment. Overexpression of Bmf reduced cell
numbers by 50% compared to GFP control at 72 h (Figure 3-2B) suggesting that Bmf is
pro-apoptotic in AECs. The extent of cell death was similar to that observed in response
to TSA. Annexin V staining, which identifies the translocation of phosphatidylserine
from the inner leaflet of the cell’s membrane to the outer leaflet and is an early event in
apoptotic cells 25, showed that Ad-Bmf caused apoptotic cell death compared to Ad-GFPinfected controls. The apoptotic profile is very similar to that observed in response to
TSA treatment (Figure 3-2C). Treatment of bmf+/+ and bmf-/- MAECs with TSA showed
that while 50% of bmf+/+ MAECs undergo apoptosis, the bmf-/- MAECs were resistant to
TSA treatment for 18 h (Figure 3-2D). However, when we reintroduced Bmf into the
Bmf-deficient MAECs using Ad-Bmf, the TSA-induced cell death was restored,
confirming that Bmf is crucial for HDACi-induced cell death in AECs (Figure 3-2E).
3.4.3 bmf -/- MAECs are resistant to IFNγ–induced cell death.
To investigate the relevance of Bmf expression causing cell death in an in vivo
system, we chose the mouse model of asthma in which MCM is resolved after prolonged
exposure to allergen. Our findings have repeatedly shown that IFNγ is crucial for the
resolution process 6, 9, 11, 26. Therefore, bmf+/+ and bmf -/-MAECs were treated with murine
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recombinant IFNγ, and viability was assessed after 96 h of treatment. Bmf-deficiency
rendered AECs more resistant to IFNγ (Figure 3-3A), suggesting that Bmf mediated
IFNγ-induced cell death. Because Bmf expression was regulated by HDACs interacting
with its promoter, we tested the involvement of HDACs by chromatin
immunoprecipitation assays using HDAC1 antibodies. AALEB cells treated with IFNγ
for 48 h showed decreased association of HDAC1 with the Bmf promoter compared to
non-treated controls (Figure 3-3B), suggesting that IFNγ inactivated HDAC1 to induce
Bmf promoter activity.
3.4.4 Bmf expression is important during the resolution of mucous cell metaplasia.
These results indicated that the resolution of allergen-induced MCM may be
mediated by IFNγ. Therefore, we postulated that Bmf expression may be increased
during resolution when dying cells appeared to detach from the basement membrane
(unpublished). Indeed, Bmf protein was detected by immunohistotchemistry in the lung
tissues of mice exposed to ovalbumin for 15 d (Figure 3-4A), when epithelial cell
numbers are reduced 11. To further address the question as to whether Bmf is important
during the resolution of MCM, 15 bmf+/+ and 15 bmf -/- mice were exposed to allergen.
Lung tissues were harvested at 5, 10, and 15 d after exposure, and the number of mucous
cells per mm of basal lamina was quantified. The bmf-/- mice did not show a statistically
significant decrease in mucous cell numbers at 15 d post allergen exposure as did the
bmf+/+ mice, suggesting that Bmf expression is important for the reduction of mucous cell
numbers (Figure 3-4B).
RNA was extracted from AECs captured by LCM and analyzed using qRTPCR21. Muc5ac, a mucin gene that constitutes most of the induced mucin following
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inflammatory responses 27, showed strong induction at 5 d post allergen exposure as
expected and was decreased at 10 and 15 d in both the bmf+/+ and bmf -/- mice (Figure 34C). This suggests that the increased presence of mucous cells in the bmf -/- mice at 15
days is not a result of increased muc5ac mRNA levels.
Eleven Bcl-2 family members that are important in AEC regulation including Bik, Bax,
and others were analyzed. While no significant change was observed for other Bcl-2
family members, Bax and Bik mRNAs were significantly increased in the bmf-/- airways
at 15 d post-exposure compared to bmf+/+ airway cells (Figure 3-4D), while in the bmf+/+
mice bax mRNA levels decreased at 15 days and bik mRNA levels remained unchanged
(data not shown). A delayed increase in Bax and Bik in bmf+/+ mice expression suggests
that mucous cell death may be delayed in the knockout animals.
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3.5 DISCUSSION
In the present study we show that HDAC inhibitors induce Bmf expression that is
sufficient to induce apoptosis in AECs. Studies show that the Bcl-2 family of proteins
and the intrinsic cell death pathway are important in HDACi-induced cell death in
malignant cells 28, but it is likely that HDACi-induced cell death is cell type specific,
because the extrinsic pathway is important in cell death for glucocorticoid-resistant acute
lymphatic leukemia cells 1. Studies suggesting that nonmalignant cells undergo
apoptosis, while normal cells are protected lead to questions about how normal primary
lung epithelial cells respond to HDACi treatment. Recent reports show that TSA has
apoptotic effects in primary human eosinophils, neutrophils, and macrophages 29. It has
also been reported that TSA treatment increases apoptosis in neuronal cells rendering
these cells more vulnerable to certain neurotoxins and increasing susceptibility to
Parkinson’s disease 30. It is clear that HDACis have varying effects in different cell types
and that the exact mechanisms of HDACi-induced cell death are still being elucidated. It
is important to understand the effects of HDACis on normal cells, because these agents
are in clinical trials for the treatment of human diseases and have implications for the
treatment of chronic lung disease.
These studies also demonstrate that TSA inhibits HDAC1 association with the
Bmf promoter, increasing acetylation levels of histones 3 and 4. To thoroughly explore
the effects of HDACis on Bmf mRNA expression, HDACis from three major classes of
inhibitors were tested: TSA of the hydroxamic acid class, sodium butyrate of the
carboxylic acid class, and MS-275 of the benzamide class 28, all of which were very
strong inducers of Bmf mRNA (our manuscript in review). Of particular interest was the
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induction of Bmf by MS-275, which unlike the other inhibitors specifically targets Class I
HDACs, narrowing down the HDAC responsible for repression of Bmf to HDAC1,
HDAC2, or HDAC8 28. This information as well as data suggesting that the
overexpression of HDAC1 in gastric carcinoma cells reduces Bmf expression 13 led us to
investigate the effects of HDAC1 in Bmf regulation in AECs. HDAC1 is important for
transcriptional repression of genes in AECs such as, Cyclooxygenase 2 (Cox 2). HDAC1
degradation occurs in response to diesel particle exposure, thus upregulating Cox 2,
causing inflammation, and consequently leading to asthma exacerbations and COPD 31.
HDAC1 is targeted for degradation preferentially over HDAC2 and HDAC3 31, and may
be a very important enzyme for gene regulation in AECs.
Bmf-deficient MAEC numbers are not reduced in response to IFNγ treatment.
Because bmf-/- MAECs behave similarly in response to HDACi treatment, the idea that
HDAC1 regulates Bmf in response was tested. ChIP demonstrated that HDAC1 is
displaced from the Bmf promoter in response to IFNγ. Although HDAC1 is displaced
from the Bmf promoter in response to IFNγ treatment similarly to what is seen in
response to HDACi treatment, we do not detect an induction of Bmf mRNA or protein
when treating wild-type MAECs with IFNγ. Future studies that focus on capturing the
dying cells after IFNγ treatment by using a caspase inhibitor will be important to assess
whether the dying cells may express Bmf. IFNγ-induced cell death is a slow process
showing a 30% reduction in AEC numbers after 72 h of treatment in nonconfluent cells
17

. In AECs, HDACi treatment is a potent killer; 50% of AECs undergo cell death after

18 h of treatment. Because AECs are naturally exposed to IFNγ, it is a physiologically
relevant 6, 11, 12, 17 system and perhaps more subtle and regulated in its effects. AECs are
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not normally exposed to HDACis, possibly explaining why the effects of Bmf induction
are so widespread. Another interesting point is that although we see displacement of
HDAC1 in response to IFNγ treatment, it may not be accompanied by hyperacetylation of
histone tails. Research suggests that HDACs 1, 2, and 3 are necessary for IFNγ signaling
through STAT132, and HDAC inhibition as a result of HDACi treatment prevents nuclear
translocation of STAT1. HDACs may be recruited to another location other than the Bmf
promoter within the nucleus in response to IFNγ for specific functions relating to STAT1
signaling. IFNγ causes many effects on AECs, some of which are not fully understood at
this time; therefore, further studies looking at the functional response of Bmf to IFNγ are
necessary.
The findings from the in vivo mouse asthma model show that Bmf expression is
important for the resolution of MCM, because in its absence the clearance of hyperplastic
mucous cells is abrogated. Although Bmf protein was detectable at 15 d of allergen
exposure, the mRNA level showed no overall change. Bmf protein is expressed at 15 d
post exposure, but there is no induction of Bmf mRNA at 10 and 15 d when compared to
5 d. Immunohistochemistry studies demonstrate that Bmf protein is induced in
approximately 20% of epithelial cells; induction of mRNA levels in this small population
may be too subtle when considering all epithelial cells for mRNA analysis. It also may
be that induction of Bmf mRNA is actually seen at times other than 5, 10, or 15 d; it may
occur at an earlier or later time point. Further experiments with a more expansive time
course will provide insight into this question. A heterogeneous mixture of cells is
collected for LCM from the epithelium, including ciliated and nonciliated mucussecreting cells, which may offer another explanation as to why Bmf mRNA levels do not
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appear to be induced in the exposure model. The different cell types of the epithelium
may have different expression levels of Bmf. The initial increase in total AEC number
seen in the bmf+/+ mice, which reflects increased mucous cell numbers at 5 d, is not
observed in the bmf-/- mice. These perplexing results lead to the hypothesis that the total
cell number does not increase because the ciliated cells are turning over and the
nonciliated mucous secreting cells are maintained in the Bmf-deficient airways. One
type of cell is dying while the other type is simultaneously proliferating, so no overall
effect is detected. Evidence suggests that epithelial cells have different expression
patterns that affect their identities. For instance, the loss of transcription factors E2f4 or
foxj1 results in a loss of ciliated cells in the epithelium 33, 34. Other examples of ciliated
cell-specific genes include structural proteins such as β-tubulin IV 27. Examples of genes
specific for mucous-secreting cells include Muc5ac, Clara Cell Secretory Protein (CCSP),
and Rab27a 27, 35. These mechanisms are complex; however, they support the idea that
cell-type specific regulation is a factor in the development and maintenance of the airway
epithelium. Further studies are important to illuminate the validity of this hypothesis.
Immnofluorescence experiments are underway to locate Bmf protein in sections of
allergen-exposed airways, while co-staining for markers specific for ciliated cells and
nonciliated mucus-secreting cells. The development of AEC cultures that consist
predominantly of mucus-secreting cells or ciliated cells will help to elucidate whether
Bmf regulates cell death in these cells.
Mucous cell metaplasia in response to allergen exposure is characterized by the
induction of Muc5ac mRNA levels, which is the predominant mucin gene induced in
AECs 27, 36. Although mucous cells are sustained at 15 d post exposure in the Bmf-
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deficient animals, Muc5ac mRNA levels reflect those observed in the wild-type animals;
levels are high at 5 d and reduced at 10 and 15 d. This indicates that resolution is
important for the reduction of cell numbers; mucin protein can still exist within the
mucous cells while Muc5ac mRNA levels have returned to pre-allergen exposure levels.
Further investigation into the finding that there are differences in expression of
Bcl-2 family members, which are major regulators of IFNγ-induced cell death, and the
resolution of MCM may provide information as to why MCM is not resolved in the bmf-/mice. LCM and real-time PCR results in the Bmf-deficient animals show an induction of
Bik and Bax at 15 d, an induction not seen in the wild-type animals. Suggesting that
regulation differs in the Bmf-deficient animals, this finding leads to the question as to
whether Bax is translocating to the ER in the bmf-/- animals, as is seen in wild-type
animals or whether the function of Bik is abrogated in the absence of Bmf, delaying cell
death. Other data suggest there may be an important relationship between Bik and Bmf;
when overexpressing Bmf in bik-/- MAECs cell death is delayed by 24 h (unpublished
data) in comparison to wild-type MAECs. Cell death is also delayed when Bik is
overexpressed in bmf-/- MAECs compared to wild-type cells. These two proteins may
function together to carry out cell death in AECs. This is an important area that requires
further investigation and the development of a bmf-/-bik-/- mouse to test this hypothesis.
In conclusion, these results show that HDACis induce Bmf expression through the
displacement of HDAC1 from the Bmf promoter, causing cell death in AECs through the
induction of Bmf. Furthermore, resolution of allergen-induced MCM is mediated by
IFNγ blocking HDAC1 interaction with the Bmf promoter, causing an induction in Bmf
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expression. These findings support further investigations to evaluate whether HDAC1specific inhibitors may be effective for reducing MCM in asthma and COPD.
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3.6 FIGURES AND LEGENDS
A)

B)

D)

E)

C)

D)E)

Figure 3-1. Histone deacetylase inhibitors (HDACis) induce Bmf expression
through increasing histone acetylation and displacement of HDAC1.
(A) qRT- PCR results show that Bmf mRNA is induced in response to HDACi, TSA in
three different lung cancer cell lines: H1568, H2023, and H2228. (B) TSA induces Bmf
mRNA and (C) protein levels in MAECs. (D) Lysates containing extracted histones from
TSA-treated AALEBs show global acetylation of histone 4. (E) Chromatin
immunoprecipitation of nuclear lysates prepared from AALEB cells treated with TSA,
using anti-acetylhistone 3, anti-acetylhistone 4, and anti-HDAC1 reveal that HDACis
enhance acetylation of histone 3 and histone 4, and diminish the association of HDAC1
with the Bmf promoter.
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A)

B)

C)

D)

E)

Figure 3-2. Bmf causes apoptosis.
(A) AALEB cells were treated with nothing, 300 nM TSA, 5 mM NaB or 5 µM of MS275 for 18 hr. Cells were harvested and quantified using trypan blue exclusion. Cell
numbers were reduced significantly in HDACi-treated groups. (B) MAECs
overexpressing Bmf protein as a result of infection with Ad-Bmf at 50 MOI show a
reduction in cell number compared to MAECs infected with Ad-GFP at 50 MOI. (C)
Annexin V staining of TSA-treated MAECs compared to non-treated and Ad-Bmfinfected MAECs compared to Ad-GFP infected MAECs. D) HDACis induce cell death
in bmf+/+ MAECs; however, bmf-/-MAECs are resistant to HDACi-induced cell death.
bmf+/+ and bmf-/-MAECs were treated with 300 nM of TSA for 18 hr. Cells were
quantified by trypan blue exclusion assay. E) bmf-/-MAECs, were infected with 50 MOI
Ad-Bmf or Ad-GFP and treated with TSA for 18 hr. Cells were harvested and quantified.
Ad-Bmf restores cell death compared to Ad-GFP-infected cells treated with HDACi.
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A)

B)

Figure 3-3.IFNγ-induced cell death is reduced in Bmf-deficient MAECs.
A) The percentage of viable cells is not decreased after 96 hr of IFNγ treatment in bmf-/MAECs compared to bmf+/+. Cells were harvested and quantified using trypan blue
exclusion. B) Chromatin immunopreciptiation of nuclear lysates prepared from AALEB
cells treated with IFNγ show that HDAC1 is displaced from the Bmf promoter after 48 h
treatment.

A)

C)

B)

D)

Figure 3-4. Bmf is important during the resolution of MCM. A) Bmf protein is induced
in vivo during resolution of MCM. Immunohistochemistry was used to stain for Bmf in 0 d,
5 d, 10 d, and 15 d sectioned tissues of ovalbumin-exposed mice. A statistically greater
number of cells are positive for Bmf in the 15 d tissues. B) Resolution of MCM as a result of
prolonged exposure to allergen is inhibited in bmf-/-MAECs. ABH&E was used to stain
sectioned tissues from 5 d, and 15 d bmf-/-and bmf+/+ mice. Tissues from five mice from each
group were blinded, and mucous cells/mm basal lamina were quantified. There is a
statistically significant decrease in mucous cell numbers at 15 d compared to 5 d in the wildtype animals. This difference is not observed in the bmf-/-mice. C) qRT-PCR showing
Muc5ac mRNA levels from LCM captured AECs from the right lungs of 5 and 15 d
ovalbumin-exposed bmf+/+ and bmf-/-mice. D) LCM captured AECs from ovalbumin-exposed
mice show altered mRNA expression levels of other Bcl-2 family members in the Bmfdeficient mice. qRT-PCR results show that Bax and Bik mRNA levels are significantly
induced at 15 d in the AECs of ovalbumin-exposed bmf-/-mice compared to 5 d.
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Chapter 4
Discussion
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In the present studies, we investigated the regulation and function of Bmf in
AECs with a focus on two apoptotic stimuli, IFNγ and HDACis. IFNγ is important for
the regulation of cell numbers in the airway epithelium and causes the resolution of
MCM. Because MCM is a crucial component of chronic lung disease, including asthma,
these studies contribute to clarifying the role of Bmf in asthma. Our studies on the
regulation of Bmf by HDACis was based on previous studies in cancer cells and led us to
identify Bmf as a mediator of HDACi-induced cell death. Therefore, HDACis may be
useful for treatment of chronic lung disease to reduce MCM.
Specific questions generated from the major findings of these studies.
1) Is the suppressive effect of p53 on Bmf important for IFNγ-induced cell death?
2) Although Bmf is downregulated by IFNγ it appears to be important in IFNγinduced cell death; therefore, we are interested to investigate what role Bmf plays in
IFNγ-induced cell death.
3) Why do Bmf expression levels vary greatly between tissue and cell types, and
what is the role of the different Bmf isoforms in AECs?
4) The fact that Bmf is important during the resolution of MCM suggests that
Bmf functions in conjunction with other pro-apoptotic Bcl-2 family members that are
also crucial for this resolution.
5) Do mouse airway epithelial cells (MAECs) from Bmf-deficient mice attach to
cell culture plates better than Bmf-sufficient MAECs because their survival is longer
during the time they are detached from the basement membrane?
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6) Can HDACis be used to induce Bmf specifically in mucous cells to initiate cell
death in metaplastic mucous cells?

4.1 The role of p53 in the regulation of Bmf expression by IFNγ and HDACis
Experiments presented here show that IFNγ treatment causes nuclear
accumulation of p53 and increased association with HDAC1. This association resulted in
the reduction of acetylated p53 and the interaction of p53 with the Bmf promoter (Figure
4-1). p53 is activated through posttranslational events, such as acetylation and
phosphorylation 1. The acetylation of p53 by histone acetyltransferases (HATs) induces
p53-dependent growth arrest and apoptosis, while deacetylated p53 promotes cell
survival in cancer cell lines 1. In support of these previous findings, IFNγ deacetylated
p53 and suppressed Bmf expression, suggesting that p53 has an inhibitory role in IFNγinduced cell death. This cell death inhibitory role of p53 requires further investigation,
because of the overwhelming evidence for the pro-apoptotic role of p53 in response to
many stimuli 2. However, there is support that p53 does play an anti-apoptotic role as
well. Physiological-relevant levels of p53 protect fibroblasts from undergoing serum
withdrawal-induced apoptosis 3. In addition, anti-apoptotic roles for p53 in cellular
processes such as DNA repair and the cell cycle have been established 4. Experiments
designed to identify the region of p53 that interacts with HDAC1 will allow for the
development of a p53 mutant that is unable to interact with HDAC1. IFNγ would be
unable to deacetylate this mutant p53 and sustaining acetylated p53 would enhance cell
death, if this pathway is suppressing cell death.
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IFNγ affects the airway epithelium in several ways; it mediates the resolution of
airway epithelial hyperplasia by inducing apoptosis5, 6, it has inhibitory effects on the
development of mucous cells 7, and at low concentrations it enhances the development of
mucous cell metaplasia (MCM) 8. Our studies demonstrate that two Bmf isoforms are
expressed in AECs, so it is possible that IFNγ affects the regulation of Bmf isoforms
differently. Studies in lymphoma cells show that three Bmf transcripts are translated into
isoforms of Bmf. Bmf (Bmf I) is pro-apoptotic, and Bmf II and Bmf III promote survival
and growth 9. Through the development of Bmf transcript-specific primers, it will be
possible to delineate which forms of Bmf are affected in AECs in response to IFNγ.
However, because Bmf II, a pro-survival protein, was suppressed by IFNγ, expressing the
p53 mutant that is deficient in interacting with HDAC1 will likely suppress cell death.
These studies will clarify whether the suppressed Bmf will enhance or suppress cell
death.
Although Bax is crucial for IFNγ-induced cell death 10, Bax mRNA is also
downregulated in response to IFNγ. Future studies will investigate whether p53 regulates
Bax and Bmf mRNAs by similar mechanisms. Western blot analysis of lysates from p53
-/-

and p53 +/+ MAECs treated with IFNγ will show whether p53 suppresses Bmf or Bax,

supporting the idea that p53 may have an inhibitory role in the IFNγ-induced cell death
pathway.
Previous studies show no difference in IFNγ-induced cell death in p53 +/+ and p53
-/-

MAECs at 96 h 11. However, it is important to analyze the cell death of p53 -/- MAECs

at 24, 48, and 72 h because cell death may be delayed in the p53-deficent cells. It is
possible that at earlier time points the p53 -/- MAECs are more resistant to cell death and
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that shortly before 96 h a p53-independent mechanism drives the cell death process so
that a large number of cells undergo apoptosis in a delayed manner. This may account
for the similar cell numbers in the p53+/+ and p53-/- MAECs after 96 h of IFNγ treatment.
IFNγ dramatically induces Noxa mRNA and protein levels within 1 h (data
unpublished). Therefore we investigated whether Noxa mediates IFNγ-induced nuclear
accumulation of p53. Western blot analysis of nuclear lysates from noxa+/+ and noxa-/MAECs treated with IFNγ (data not shown) showed no difference, suggesting that Noxa
is not involved in the accumulation of p53 in the nucleus. Future studies will test
whether other signaling proteins that are activated by IFNγ treatment including JNK or
ERK1/2 11 are involved in IFNγ-induced effects on p53.
Our studies show that p53 suppressed the Bmf promoter activity not only in
response to IFNγ but also following UV irradiation (Figure 2-2) or cytochalasin D
treatment, (Appendix C). Bmf promoter activity is also suppressed in response to
HDAC1 in cancer cell lines 12. The fact that HDACi treatment acetylated histones 3 and
4 and displaced HDAC1 suggests that chromatin remodeling plays a crucial role for Bmf
regulation in AECs as well. Acetylation of histone tails causes DNA to relax, allowing
transcription factors to access the Bmf gene13. The Bmf gene promoter does not contain
any p53-binding motifs; therefore, it is likely that p53 is part of a protein complex that
suppresses transcriptional activity. It is important to identify these p53-interacting
proteins in order to elucidate the role of p53 in the suppression of Bmf. Identification of
these proteins will be the first step in clarifying the molecular events that occur when p53
is deacetylated by HDAC1 in response to IFNγ. In addition, these studies will help
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clarify the role of p53 in chromatin remodeling that appears to be independent from
HDAC-mediated suppression of Bmf transcription.
4.2 The role of Bmf in IFNγ-induced cell death
Our studies show that bmf -/- MAECs are resistant to IFNγ-induced cell death at 96
h (Figure 3-3). Bmf mRNA and protein expression were downregulated at 48 h, however
Bmf levels have not been examined at 96 h of IFNγ treatment in non-differentiated cells.
IFNγ induces cell death in 30 % of AECs after 72 h, but in 50% after 96 h. Bmf may be
important for the accelerated levels of apoptosis observed between 72 and 96 h. Because
Bmf may be induced in expression at later time points when cells undergo cell death,
future studies will examine cell death in bmf -/- MAECs over 24, 48, and 72 h of IFNγ
treatment. If cell death is delayed over 96 h, we will conclude that Bmf is important for
cell death at the later time points in response to IFNγ.
The findings that Bmf expression is suppressed by IFNγ while Bmf mediates
IFNγ-induced cell death suggest that the low levels of Bmf protein present in AECs are
sufficient to cause cellular death. It is possible that controlling Bmf at low levels may be
crucial to ensure the selective induction of cell death in hyperplastic AECs rather than
eliminating the majority of AECs that are in the G0 phase if high levels of Bmf were to
be expressed. Immunofluorescent staining to observe the translocation of Bmf protein in
response to IFNγ in MAECs will help identify the cell compartments and the proteins
involved.
As discussed in Chapter 3, another explanation for this paradox may be that Bmf
is only necessary to facilitate cell death in mucus-secreting cells of the epithelium (Figure
4-2) while being downregulated in the other cell types. Because our in vitro studies used
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non-differentiated epithelial cells, the regulation may not represent the complexity of
diverse cell types found in the airway epithelium.
In an effort to explore the cell type-specific affect of Bmf in mucus-secreting and
ciliated cells of the epithelium bmf-/- and bmf +/+, MAECs were grown on Transwell
membranes until confluent and driven to differentiation in air-liquid interface conditions.
These cultures were treated with IFNγ for 48 h to simulate the conditions of prolonged
allergen exposure in airway epithelia in vivo. The purpose of this study was to test
whether IFNγ has a specific effect on the Bmf-deficient cultures, and to use
immunostaining to evaluate whether there is heterogeneous expression of Bmf within the
cell types in wild-type cultures. This study is in progress. ABH&E staining will allow
for the quantification of cell numbers/mm basal lamina. Immunofluorescent staining will
visualize ciliated and mucous cells with antibodies to β-tubulin or Muc5ac, respectively.
Co-immunostaining for Bmf in the bmf+/+ MAECs will show whether expression is
specific to the different cell types. Our hypothesis is that there will be more mucous cells
in the IFNγ treated bmf-/- cultures and fewer ciliated cells, and that Bmf expression will
co-localize with Muc5ac expression. Alternatively, future experiments will investigate
IFNγ-induced Bmf expression in the various cell types of the airway epithelium using
cultures that predominantly consist of either mucus-secreting or ciliated cells.
To explore the cell type-specific function of Bmf in vivo, transgenic approaches
can be used either to overexpress Bmf using cell type-specific promoters or by using the
Cre/loxP system to target gene expression in mucus-secreting or ciliated cells.
Expression of a gene can be targeted to Clara cells by driving the expression of Crerecombinase with the CCSP promoter 14. To selectively delete Bmf in these cells, CCSP
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can be flanked by two lox P sites. A mouse expressing Cre-recombinase under the CCSP
or the FOXJ1 promoters 15 will then be bred into a mouse expressing floxed Bmf. When
Cre-recombinase is expressed, the segment of DNA in between the two lox P sites will be
excised, knocking out Bmf either in Clara or ciliated cells. Clara cells differentiate into
mucus-secreting cells of the small airway and will provide information about the function
of Bmf in all mucus-secreting cells. Generating such mice will allow for the
investigation of Bmf function in mucus-secreting or ciliated cells in vivo because
prolonged exposure of these transgenic mice to allergen will allow the delineation of Bmf
function in mucous cells. Our hypothesis is that Bmf-deficient mucus-secreting cells will
be unable to undergo apoptosis, while apoptotic pathways will be unaffected in ciliated
cells.
4.3 Bmf expression in the lung
Protein lysates extracted from various murine organs showed that significant Bmf
protein levels are found in the lung liver and spleen tissues but not in the heart (Appendix
A and data not shown). Interestingly, while high levels of Bmf protein were detected in
lung tissue, they are not detected in MAECs. Previous studies have analyzed various cell
types of the hematopoietic compartment for Bmf protein expression; very high
expression levels are found in the immature CD4+8+ thymocytes, while much lower
levels are found in the mature resting T cells or mitogen-stimulated T cell lymphoblasts.
Bmf expression is found throughout the B cell development with the exception of pro-B
cells, in which no expression is detected 16. Because, in cultured AECs, Bmf protein
expression is detected at much lower levels than that detected in the lung tissue, we
assume that Bmf is expressed in cell types other than epithelial cells. Immunofluorescent
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studies are needed to identify the cell types that express Bmf protein within the lung.
Should Bmf be expressed in AECs of intact lungs, we will conclude that epithelial cells
when cultured suppress Bmf expression. It is also possible that Bmf is expressed in types
I and II cells, or in macrophages, both of which are abundant in normal lungs. However,
because the lung structure and function of bmf-/- mice appear normal, Bmf does not seem
to have a role in the development of the lung.
Similar to findings of Verna et al. in hematopoietic cells, we find that two
isoforms of Bmf are expressed in lung tissue as well as AECs1. Because different
isoforms of Bmf with potentially different functions are expressed in the lung, we have
generated an adenoviral expression system that expresses a single pro-apoptotic isoform
of Bmf. However, when AECs are infected with this virus two Bmf-specific protein
bands were detected on Western blots (Appendix E). The smaller band corresponds to
the molecular weight of Bmf, suggesting that the larger Bmf isoform may actually
represent Bmf with posttranslational modifications. Future studies will also generate
adenoviral expression vectors to specifically express the larger Bmf isoforms and allow
the investigation of these isoforms in AECs.
4.4 The functional role of Bmf during resolution of MCM
Results from the allergen exposure study suggest that mucous cell numbers
remain higher in the bmf-/- compared to bmf+/+ mice after 15 d of allergen exposure.
However, Bik and Bax were induced in epithelia of bmf-/- mice exposed to allergen for 15
d. These findings suggest that resolution of AEC hyperplasia was delayed in bmf-/- mice
and may occur if mice are exposed for longer periods. Therefore, in the future, 30 mice
will be exposed to allergen and groups of 5 sacrificed at 0, 2, 5, 10, 20, and 30 d. Earlier
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time points will be included to determine whether Bmf mRNA may be increased in bmf-/mice at 2 or 5 d. Analysis of the airway epithelium of bmf-/- mice at 20 and 30 d will
allow us to evaluate whether the delayed induction of Bik and Bax will drive the
resolution of MCM.
IFNγ-induced cell death is a complex process involving different members of the Bcl2 family of proteins such as, Bax, Bak, Noxa, and Bik. The finding that IFNγ-induced
cell death is inhibited in bmf-/- MAECs suggests that Bmf mediates this cell death
process. In addition, overexpression of Bik protein, a central mediator of IFNγ-induced
cell death in AECs11, induced Bmf mRNA (data not shown). In bik-/- MAECs, Bmf
expression causes cell death 24 h later than it does in bik+/+ MAECs (unpublished). Cell
death is also delayed when Bik is expressed in bmf- /- compared to bmf+/+ MAECs. These
results support the idea that Bik and Bmf may function in tandem. Because Bik is
induced in bmf-/- MAECs (Figure 3-4), we hypothesize that Bik is upstream of Bmf. Bik
is induced at 24 h 11 and may cause Bmf to translocate to specific organelles to cause cell
death. Immunofluorescent staining in time course experiments after IFNγ treatment will
assess the time of Bmf translocation. In addition, infection of cells with adenoviral
vectors expressing Bik will assess whether Bik mediates Bmf translocation. Control
studies will use bik-/- MAECs to elucidate whether Bik mediates IFNγ-induced Bmf
translocation.
To further evaluate the functional relationship between Bmf and Bik, it is important
to generate cells in which both genes are deleted. Breeding of bmf-/-bik-/- mice would
allow for the investigation as to whether these proteins are dependent on one another to
carry out cell death. We assume that the mutual deletion of these two proteins would
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render AECs unable to undergo apoptosis in response to IFNγ. Reintroducing expression
of each of these proteins individually will allow us to examine the role and function of
each protein and determine whether both proteins are required to restore cell death in
response to IFNγ.
Preliminary data from the first allergen exposure study suggest that inflammatory
cell numbers are higher in the lung lymph nodes from Bmf-deficient mice compared to
wild-type mice (Appendix F). When stimulated these bmf-/- lymphocytes trend toward
producing more IL-13 and IFNγ than the wild-type controls after 10 d of allergen
exposure. In addition, it is important to evaluate the inflammatory response during the
time course of allergen exposure in bmf+/+ and bmf-/- mice. This can be determined with
differential cell counts and analysis of Th2 cytokines in the bronchoalveolar lavage
collected at the time of lung harvest. This is important because previous studies show
that Bmf is involved in cell death of hematopoietic cells16, and mucous cells may be
sustained in bmf-/- mice due to prolonged survival of inflammatory cells that produce Th2
cytokines.
Results from the allergen exposure study presented in Chapter 3 (Figure 3-4B)
suggest that mucous cells in the bmf-/- mice have a survival advantage over the mucous
cells in the bmf+/+ mice. Total AEC numbers at 5 d in the bmf-/- allergen-exposed mice
were not elevated as they were in wild-type animals; however, mucous cell numbers were
increased. There are several possible explanations for this apparent discrepancy. First,
the fact that the total cell numbers were not increased suggests that Bmf may have an
important role in promoting survival of ciliated cells. In the absence of Bmf, these cells
may turnover at an accelerated rate. Second, studies suggest that cytokines such as, Il-13

	
  

81

can alter the differentiation of ciliated cell 17 and increase the proportion of secretory
cells18, so it is possible that Bmf-deficiency alters the rate of ciliated cell differentiation
into mucous cells.
4.5 The role of Bmf in attachment of AECs to the basement membrane
Deficiency in Bmf greatly improved attachment and growth. This was observed
when bmf-/- and bmf+/+ MAECs were grown in serum-free medium and without collagen
coating of culture plates, conditions that improve attachment of MAECs, (Appendix D).
This finding may be explained by the fact that Bmf may have an important role in the
death of cells during the attachment process. Studies show that Bmf sensitizes mammary
epithelial cells to detachment-induced cell death19. Therefore bmf-/- MAECs may have a
longer life span and a better chance to attach to the culture plate and grow. Alternatively,
Bmf may be a crucial protein in sustaining isolated stem cells that can proliferate and
establish MAEC cultures 20.
Disruption of tight junction proteins, such as occludin and claudin-1, cause cell
death and epithelial cell extrusion, a process in which contraction of actin and myosin in
neighboring cells extrudes dying cells from the epithelial layer 21, 22. Experiments in
differentiated HAECs show that the disruption of cell-to-cell junctions causes apical
extrusion, which is shown to be anoikis, or detachment-induced cell death 22. Because
we have observed epithelial cells that appear to be extruded during the reduction of
hyperplastic epithelial cells, we assume that anoikis and apical extrusion may be involved
in the removal of airway epithelial cells. In the future, immunofluorescent staining and
3-D confocal images will be used to visualize whether Bmf-expressing cells show apical
extrusion in differentiated MAECs and in murine airways in vivo. In addition, expressing
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Bmf using Ad-Bmf in differentiated cultures combined with immunofluorescent staining
for occludin and claudin-1, as well as a marker for apoptosis such as caspase-3, may
establish that Bmf expression causes AEC extrusion. These studies will clarify whether
Bmf expression can be used as a marker for cells that are extruding from the epithelium.
Because these cells that have the potential for metastasis 23, the studies may have
significance in identification of metastatic cells in cancer.
4.6 The potential utility of HDACi therapy in treating chronic lung disease
Asthma, cystic fibrosis, and COPD are chronic airway diseases characterized by
mucous hypersecretion, which obstructs airflow and increases wheezing, coughing, or in
the case of sudden secretion can completely obstruct the airway and lead to patient death.
In addition, the presence of a large amount of mucus in the airway traps toxins and
pathogens in the airway, enhancing damage to the lung 24. Because our findings suggest
that Bmf is important for mucous cell apoptosis, and that HDACis induce apoptosis
through the induction of Bmf, HDACis may be useful in the treatment of chronic lung
disease. Treatment of differentiated MAECs with IL-13 to induce MCM, followed by
treatment with HDACis will show whether this approach reduces MCM. Similarly, we
will examine whether HDACis are efficient in reducing allergen-induced MCM in mice.
In summary, our results suggest that Bmf is an important pro-apoptotic protein for
regulation and maintenance of AECs. Bmf is important for AEC death in response to
IFNγ and HDACi; these apoptotic stimuli upregulate the transcription of Bmf by
modifying the interaction of HDAC1 with the promoter (Figure 4-3). Although we
cannot eliminate the idea that apoptotic stimuli regulate Bmf posttranslationally by
causing it to translocate from the cytoskeleton to the mitochondria as proposed by
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Puthalakath et al. in Figure 1-1, the regulation of Bmf in AECs may be unique because
increased transcription and protein synthesis may provide sufficient Bmf to directly affect
mitochondria and cause cell death. In addition, efficiency of Bmf-induced cell death
appears to vary depending on cell types of the airway epithelium. Exploring the
functional roles of Bmf may provide new means of treating chronic lung diseases.
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Figure 4-1. Model for regulation of Bmf mRNA by p53 in response to IFNγ.
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Figure 4-2. Model for the cell-type specific effect Bmf potentially has in mucus-secreting
cells of the epithelium. Cells removed from the epithelium are replaced by neighboring cells.
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Figure 4-3. Model for the regulation of Bmf by IFNγ and HDACis in AECs.
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APPENDIX A:
Expression of Bmf protein in lung tissue
Studies from Verna et al.1 demonstrate that Bmf protein expression is variable in
different cell types. To characterize the bmf-/- mice and the anti-murine Bmf 17A9
monoclonal antibody, both of which were gifts from A. Strasser (Walter and Eliza Hall
Institute, Melbourne, Australia), a Western blot was run comparing lung and heart tissue
from bmf-/- and bmf +/+mice. The antibody described in Verna et al. 1 shows two distinct
bands, which represent the 25 kD and 30 kD isoforms of Bmf. Two light background
bands also appear in the lung extracts from bmf-/- and bmf +/+mice. These bands are
cross-reacting products and presumably unrelated to Bmf. Bmf protein expression was
detected in the lung tissue, while none was detected in the heart tissue.
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Figure and Figure Legend (Appendix A)

Appendix A. Bmf protein expression in heart and lung tissue. Lung (lane 1) and
heart (lane 2) tissues from bmf-/- and bmf +/+mice were homogenized on ice in 100 µl of
saline with protease inhibitors using a tissue homogenizer. After addition of 50 µl of 3x
RIPA buffer, samples were incubated on ice for 15 min while the samples were vortexed
every 5 min and centrifuged at 14, 000 RPM for 10 min. The soluble fraction was
isolated and protein concentration determined using a BCA assay. 50 µg of protein was
used for the Western blot as described earlier (3.3.6). Immuoblot was probed for Bmf
(17A9) and the loading control β-Actin.
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APPENDIX B
Growth factor withdrawal induces Bmf mRNA

The medium used to grow AECs in culture must contain nutrients and growth
factors, which include retinoids, epidermal growth factor (EGF), hydrocortisone,
transferring, triiodothyronine, epinephrine and insulin. Studies report that growth factors
are an important component in medium for growing and maintaining healthy epithelial
cells in culture 2. Epithelial cells grown in medium without the growth factors, insulin,
and EGF, have difficulty attaching to the cell culture plates. Because withdrawal of EGF
induced Bmf expression in MCF-10A mammary epithelial cells3, we carried out this
experiment in AECs. Minimal Bmf induction was observed when either EGF or insulin
was individually removed from the medium; however, a significant induction of Bmf
mRNA was seen when insulin and EGF were removed from the medium.
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Figure and Figure Legend (Appendix B)

A)

B)

Appendix B. Growth factor withdrawal reduces AEC numbers and induces Bmf
mRNA.
Bmf mRNA is induced in response to growth factor withdrawal. AALEB cells were
plated to be 30% confluent and 24 h later maintained with or without insulin and EGF for
48 h. Cells were harvested, RNA extracted using the Qiagen RNA extraction kit, and
qRT-PCR was used to analyze Bmf mRNA expression (A). Trypan blue exclusion was
used to quantify AECs after the absence of EGF and insulin for 24 and 48 h. Growth
factor withdrawal reduces AEC numbers.
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APPENDIX C:
Cytochalasin D treatment changes Bmf mRNA expression
The disruption of actin filament integrity with either cytochalasin D or jasplakinolide
induces apoptosis in AECs, suggesting that actin may be important in the apoptotic
pathway 4. Latrunculin A treatment, another agent that disrupts actin polymerization,
induces Bmf mRNA in MCF-10A cells 3. Our studies show that the treatment of AECs
with cytochalasin D cause the AECs to round up and lose normal morphology, followed
by AEC death (unpublished). Whether this is related to the induction of Bmf seen at 24 h
is unknown.
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Figure and Figure Legend (Appendix C)

Appendix C: Treatment with cytochalasin D initially reduced but then induced Bmf
mRNA levels at 24 hr.
HCCBE cells, an AEC line derived from NHBEs, were plated in 6-well dishes, grown to
35% confluency, and 24 h later were treated with cytochalasin D at a concentration of
1µg/ml. Cells were harvested using trypsin at 0, 1, 3, and 24 h, RNA was extracted using
the Qiagen RNA extraction kit, and qRT-PCR was used to analyze Bmf mRNA levels.
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APPENDIX D:
bmf-/- and bmf+/+ MAECs grown in attachment-poor conditions
Collagen-coated culture plates and medium containing fetal bovine serum are important
for primary AEC growth and attachment. bmf-/- and bmf+/+ MAECs were plated on
culture plates without collagen and in serum-free medium. These experiments revealed
that the bmf-/- MAECs have an advantage over the bmf+/+ MAECs grown in these
conditions.
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Figure and Figure Legend (Appendix D)

Appendix: D bmf-/- MAECs are more resistant to serum deprivation when
compared to bmf+/+ MAECs.
bmf-/- and bmf+/+ MAECs (75,000) were plated in 6-well culture dishes without collagen
coating and in serum-free medium. Photomicrographs were taken at 72 h, and cell
numbers were determined after harvest at 96 h.
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Appendix E:
Expression of Bmf in AALEB cells
Infecting AALEBs with adenoviral Bmf (as described in 2.2.6) produces two Bmf
specific bands when compared to non-infected cells. The adenovirus was designed to
produce the 25kD isoform of Bmf; however, another band that is ~30kD was expressed
as well. This band is not present in the non-infected cells, nor is it expressed in cells
infected with Ad-GFP (data not shown). This second band may be the result of a
posttranslational modification of the smaller form of Bmf.
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Figure and figure legend (Appendix E)

Appendix E. Infection of AALEB cells with Ad-Bmf results in the expression of two
Bmf-specific bands. AALEB cells were infected with Ad-Bmf, and 24 h later cells were
harvested and analyzed by Western blotting using the 17A9 anti-Bmf antibody (described
in Appendix A); β-Actin was used as a loading control.
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APPENDIX F:
Lymph node cell numbers in allergen exposed bmf -/-and bmf +/+mice
Lung lymph nodes from allergen exposed bmf-/-and bmf +/+mice were removed at
the same time that the lungs were harvested at 5, 10, and 15 d of allergen exposure. We
collected these organs to investigate whether allergen exposure produced changes in the
immune response in the bmf-/-mice compared to bmf +/+.
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Figure and figure legend (Appendix F)

Appendix F. Cell numbers are greater in the lung lymph nodes of allergen-exposed
bmf-/- mice. A single cell suspension was prepared from the lymph nodes using a gentle
grinding technique. Red blood cells were lysed, and lymph node cells were resuspended in
0.5 ml of culture medium. Cells were filtered through a sterile cell strainer and then counted.
Cells were plated in medium containing either Concanavalin A or ovalbumin to stimulate
cytokine production in 48 well dishes in triplicate. Cells were harvested 48 h later, and
cytokine levels were assessed with an enzyme-linked immunosorbent assay.

	
  

102

References:
1. Verna L, Miriam Erlacher, Stephan Kiessling, Claudia Manzl, Anna Frenzel, Lorraine
O'Reilly, Andreas Strasser, and Andreas Villunger. Loss of the BH3-only protein Bmf
impairs B cell homeostasis and accelerates gamma irradiation-induced thymic lymphoma
development. The Journal of Experimental Medicine 2007;1658:15.
2. Bottenstein J, Hayashi I, Hutchings S, et al. The growth of cells in serum-free
hormone-supplemented media. Methods Enzymol 1979;58:94-109.
3. Schmelzle T, Mailleux AA, Overholtzer M, et al. Functional role and oncogeneregulated expression of the BH3-only factor Bmf in mammary epithelial anoikis and
morphogenesis. Proc Natl Acad Sci U S A 2007;104:3787-92.
4. White SR, Williams P, Wojcik KR, et al. Initiation of apoptosis by actin cytoskeletal
derangement in human airway epithelial cells. Am J Respir Cell Mol Biol 2001;24:28294.

	
  

103

